This	O
GTPase	other-biologything
protein	other-biologything
domain	O
is	O
found	O
in	O
all	O
eukaryotic	O
tubulin	O
chains	O
,	O
as	O
well	O
as	O
the	O
bacterial	O
protein	O
TubZ	other-biologything
,	O
the	O
archaeal	O
protein	O
CetZ	other-biologything
,	O
and	O
the	O
FtsZ	other-biologything
protein	other-biologything
family	O
widespread	O
in	O
Bacteria	other-disease
and	O
Archaea	other-disease
.	O

These	O
conditions	O
are	O
characterized	O
by	O
multiple	O
tumor-like	O
growths	O
called	O
hamartomas	other-disease
and	O
an	O
increased	O
risk	O
of	O
developing	O
certain	O
cancers	O
.	O

About	O
half	O
of	O
patients	O
have	O
associated	O
dystonia	other-disease
,	O
including	O
cervical	other-disease
dystonia	other-disease
,	O
writer	other-disease
's	other-disease
cramp	other-disease
,	O
spasmodic	other-disease
dysphonia	other-disease
,	O
and	O
cranial	other-disease
dystonia	other-disease
,	O
and	O
20	O
%	O
of	O
the	O
patients	O
had	O
associated	O
parkinsonism	other-disease
.	O

Defective	O
laminins	other-biologything
can	O
cause	O
muscles	O
to	O
form	O
improperly	O
,	O
leading	O
to	O
a	O
form	O
of	O
muscular	other-disease
dystrophy	other-disease
,	O
lethal	O
skin	O
blistering	O
disease	O
(	O
junctional	other-disease
epidermolysis	other-disease
bullosa	other-disease
)	O
and	O
defects	O
of	O
the	O
kidney	O
filter	O
(	O
nephrotic	other-disease
syndrome	other-disease
)	O
.	O

QKI	O
gene	O
expression	O
is	O
decreased	O
in	O
specific	O
brain	O
regions	O
in	O
SZ	other-disease
and	O
it	O
has	O
been	O
proposed	O
to	O
be	O
involved	O
in	O
SZ	other-disease
SZ	other-disease
.	O

He	O
was	O
speaker	O
of	O
the	O
New	organization-government,governmentagency
Hampshire	organization-government,governmentagency
House	organization-government,governmentagency
of	organization-government,governmentagency
Representatives	organization-government,governmentagency
for	O
one	O
week	O
before	O
he	O
died	O
from	O
COVID-19	other-disease
.	O

The	O
cytogenetic	O
location	O
of	O
the	O
gene	O
in	O
question	O
is	O
chromosome	other-biologything
3	other-biologything
,	O
specifically	O
3q11.1	other-biologything
Protein	other-biologything
S	other-biologything
deficiency	O
can	O
also	O
be	O
``	O
acquired	O
''	O
due	O
to	O
vitamin	other-biologything
K	other-biologything
deficiency	O
,	O
treatment	O
with	O
warfarin	other-disease
,	O
liver	O
disease	O
,	O
and	O
acute	other-disease
thrombosis	other-disease
(	O
antiphospholipid	O
antibodies	O
may	O
also	O
be	O
a	O
cause	O
as	O
well	O
)	O

Acquired	O
haemophilia	other-disease
A	other-disease
(	O
AHA	other-disease
)	O
is	O
a	O
rare	O
but	O
potentially	O
life-threatening	O
bleeding	O
disorder	O
characterized	O
by	O
autoantibodies	O
directed	O
against	O
coagulation	other-biologything
factor	other-biologything
VIII	other-biologything
.	O

Men	O
who	O
present	O
with	O
this	O
complaint	O
may	O
have	O
Koro	other-disease
,	O
but	O
they	O
may	O
also	O
be	O
misinformed	O
about	O
normal	O
genital	O
size	O
.	O

Hearing	O
impairment	O
may	O
also	O
be	O
the	O
result	O
of	O
certain	O
diseases	O
such	O
as	O
CMV	other-disease
or	O
Ménière	other-disease
's	other-disease
disease	other-disease
and	O
these	O
can	O
be	O
diagnosed	O
from	O
the	O
shape	O
of	O
the	O
audiogram	O
.	O

The	O
usual	O
treatment	O
of	O
a	O
standardised	O
Adie	other-disease
syndrome	other-disease
is	O
to	O
prescribe	O
reading	O
glasses	O
to	O
correct	O
for	O
impairment	O
of	O
the	O
eye	O
(	O
s	O
)	O
.	O

Some	O
of	O
these	O
mutations	O
are	O
not	O
directly	O
lethal	O
and	O
instead	O
confer	O
resistance	O
to	O
malaria	other-disease
,	O
particularly	O
in	O
Africa	location-GPE
where	O
malaria	other-disease
is	O
epidemic	O
.	O

During	O
the	O
2020	O
Coronavirus	other-disease
Pandemic	other-disease
,	O
the	O
BBC	organization-media,newspaper
announced	O
a	O
decision	O
not	O
to	O
feature	O
``	O
Land	art-music
of	art-music
Hope	art-music
and	art-music
Glory	art-music
``	O
as	O
well	O
as	O
Rule	art-music
Britannia	art-music
in	O
the	O
Last	O
Night	O
of	O
the	O
Proms	O
running	O
order	O
.	O

In	O
a	O
study	O
of	O
over	O
2500	O
people	O
resident	O
in	O
Taiwan	location-GPE
,	O
a	O
blood	O
lead	O
level	O
exceeding	O
7.5	O
microg/dL	O
(	O
a	O
small	O
elevation	O
)	O
had	O
odds	O
ratios	O
of	O
1.92	O
(	O
95	O
%	O
CI	O
:	O
1.18-3.10	O
)	O
for	O
renal	O
dysfunction	O
and	O
2.72	O
(	O
95	O
%	O
CI	O
:	O
1.64-4.52	O
)	O
for	O
hyperuricemia	other-disease
.	O

Her	O
final	O
marriage	O
was	O
to	O
Sergei	person-other
Radzinsky	person-other
,	O
whom	O
she	O
married	O
to	O
keep	O
him	O
in	O
the	O
country	O
;	O
he	O
was	O
receiving	O
treatments	O
for	O
aplastic	other-disease
anemia	other-disease
as	O
a	O
result	O
of	O
exposure	O
to	O
Chernobyl	building-other
.	O

Biotron	O
has	O
identified	O
a	O
new	O
class	O
of	O
viral	O
proteins	O
as	O
targets	O
for	O
potential	O
intervention	O
,	O
and	O
is	O
developing	O
novel	O
small	O
molecule	O
therapeutics	O
that	O
target	O
these	O
proteins	O
,	O
specifically	O
the	O
p7	other-biologything
protein	O
of	O
Hepatitis	other-disease
C	other-disease
and	O
Vpu	other-biologything
protein	O
of	O
HIV	other-biologything
.	O

Crohn	other-disease
's	other-disease
disease	other-disease
cytokines	O
are	O
of	O
the	O
type	other-biologything
1	other-biologything
(	other-biologything
``	other-biologything
Th1	other-biologything
''	other-biologything
)	other-biologything
cytokines	other-biologything
,	O
which	O
include	O
TNF-α	other-biologything
,	O
interleukin-2	other-biologything
,	O
and	O
interferon	other-biologything
γ	other-biologything
.	O
Ulcerative	other-disease
colitis	other-disease
was	O
less	O
conclusively	O
linked	O
to	O
the	O
production	O
of	O
``	other-biologything
Th2	other-biologything
''	other-biologything
cytokines	other-biologything
.	O

People	O
suffering	O
from	O
Bothnia	other-disease
dystrophy	other-disease
have	O
a	O
homozygous	other-biologything
C	other-biologything
to	O
T	other-biologything
base	O
pair	O
substitution	O
in	O
exon	other-biologything
7	other-biologything
of	O
the	O
RLBP1	other-biologything
gene	O
.	O

Neuro-imaging	O
should	O
also	O
be	O
used	O
to	O
look	O
for	O
a	O
stroke	O
,	O
tumor	O
,	O
infection	O
,	O
or	O
another	O
pathology	O
in	O
the	O
setting	O
of	O
conduction	O
aphasia	other-disease
.	O

Antithrombin	other-disease
III	other-disease
deficiency	other-disease
(	O
abbreviated	O
ATIII	other-disease
deficiency	other-disease
)	O
is	O
a	O
deficiency	O
of	O
antithrombin	other-biologything
III	other-biologything
.	O

One	O
serious	O
effect	O
on	O
envenomed	O
victims	O
is	O
hemorrhage	other-disease
syndrome	other-disease
.	O

The	O
Yellow	other-disease
Fever	other-disease
would	O
have	O
come	O
from	O
Asunción	location-GPE
,	O
Paraguay	location-GPE
,	O
brought	O
by	O
Argentine	location-GPE
soldiers	O
returning	O
from	O
the	O
war	O
just	O
fought	O
in	O
that	O
country	O
,	O
having	O
previously	O
spread	O
in	O
the	O
city	O
of	O
Corrientes	location-GPE
.	O

Trace	O
aminergic	O
hypo-function	O
is	O
particularly	O
relevant	O
to	O
ADHD	other-disease
,	O
since	O
urinary	O
and	O
plasma	O
phenethylamine	other-chemicalthing
concentrations	O
are	O
significantly	O
lower	O
in	O
ADHD	other-disease
individuals	O
relative	O
to	O
controls	O
and	O
the	O
two	O
most	O
commonly	O
prescribed	O
drugs	O
for	O
ADHD	other-disease
,	O
amphetamine	product-other
and	O
methylphenidate	product-other
,	O
increase	O
phenethylamine	other-chemicalthing
biosynthesis	O
in	O
treatment-responsive	O
individuals	O
with	O
ADHD	other-disease
.	O

In	O
Morocco	location-GPE
,	O
neonatal	other-disease
tetanus	other-disease
accounted	O
for	O
20	O
%	O
of	O
neonatal	O
deaths	O
in	O
1987	O
but	O
only	O
2	O
%	O
in	O
1992	O
.	O

Dilated	other-disease
cardiomyopathy	other-disease
implies	O
that	O
the	O
muscle	O
damage	O
has	O
resulted	O
in	O
enlargement	O
of	O
the	O
heart	O
.	O

For	O
example	O
,	O
acromegaly	other-disease
results	O
from	O
excessive	O
secretion	O
of	O
growth	O
hormone	O
(	O
GH	other-biologything
)	O
often	O
being	O
released	O
by	O
a	O
pituitary	O
adenoma	O
.	O

QT	other-disease
prolongation	other-disease
is	O
detectable	O
but	O
was	O
considered	O
to	O
be	O
too	O
low	O
to	O
be	O
of	O
clinical	O
importance	O
in	O
a	O
study	O
.	O

The	O
gunman	O
,	O
Huan	person-other
Yun	person-other
Xiang	person-other
,	O
was	O
acquitted	O
of	O
crimes	O
related	O
to	O
the	O
shootings	O
due	O
to	O
mental	other-disease
impairment	other-disease
,	O
and	O
is	O
currently	O
under	O
psychiatric	O
care	O
.	O

Loss	O
of	O
the	O
retinoblastoma	other-biologything
(	other-biologything
RB	other-biologything
)	other-biologything
protein	other-biologything
induces	O
androgen	other-biologything
receptor	other-biologything
deregulation	O
in	O
castration-resistant	O
prostate	other-disease
cancer	other-disease
by	O
deregulating	O
'	O
E2F1	other-biologything
expression	O
''	O
.	O
''	O

It	O
is	O
difficult	O
to	O
distinguish	O
from	O
,	O
and	O
has	O
been	O
found	O
to	O
co-occur	O
with	O
,	O
alexithymia	other-disease
.	O

Unlike	O
the	O
accessory	O
pathway	O
in	O
a	O
more	O
common	O
cause	O
of	O
AVRT	other-disease
,	O
Wolff-Parkinson-White	other-disease
syndrome	O
,	O
the	O
accessory	O
pathway	O
in	O
PJRT	other-disease
conducts	O
slowly	O
.	O

there	O
is	O
no	O
specific	O
treatment	O
for	O
Nipah	other-disease
virus	other-disease
infection	other-disease
.	O

Other	O
well	O
known	O
causes	O
include	O
diseases	O
of	O
the	O
kidney	other-disease
.	O

Enlargement	O
of	O
the	O
vestibular	O
aqueduct	O
to	O
greater	O
than	O
2	O
mm	O
is	O
associated	O
with	O
enlarged	other-disease
vestibular	other-disease
aqueduct	other-disease
syndrome	other-disease
,	O
a	O
disease	O
entity	O
that	O
is	O
associated	O
with	O
one-sided	O
hearing	O
loss	O
in	O
children	O
.	O

Teratogens	other-disease
such	O
as	O
stress	O
can	O
alter	O
prenatal	O
neural	O
development	O
,	O
leading	O
to	O
diminished	O
competence	O
after	O
birth	O
.	O

Health	O
issues	O
with	O
purebred	O
dogs	O
and	O
objections	O
to	O
dog	O
sports	O
and	O
dog	O
showing	O
have	O
been	O
extensively	O
covered	O
in	O
these	O
articles	O
-	O
Criticism	O
of	O
dog	O
showing	O
|	O
Genetic	other-disease
disease	other-disease
|	O
List	O
of	O
dog	O
diseases	O
|	O
Canine	O
reproduction	O
|	O
Inbreeding	O
and	O
others	O
.	O

Rotumah	person-other
was	O
born	O
with	O
hemiplegia	other-disease
and	O
cerebral	other-disease
palsy	other-disease
.	O

Other	O
important	O
considerations	O
before	O
a	O
PVE	O
include	O
co-morbidities	O
such	O
as	O
diabetes	other-disease
,	O
procedure	O
type	O
and	O
the	O
extent	O
of	O
planned	O
resection	O
.	O

The	O
expression	O
of	O
miR-181c	other-biologything
is	O
relevant	O
to	O
characterize	O
a	O
Breast	other-disease
cancer	other-disease
form	O
,	O
the	O
HER2/neu	other-biologything
.	O

The	O
joints	O
in	O
gout	other-disease
can	O
often	O
become	O
swollen	O
and	O
lose	O
function	O
.	O

Myocardial	other-disease
infarction	other-disease
(	O
``	O
Heart	other-disease
attack	other-disease
''	other-disease
)	O
refers	O
to	O
heart	O
muscle	O
damage	O
due	O
to	O
insufficient	O
blood	O
supply	O
,	O
usually	O
as	O
a	O
result	O
of	O
a	O
blocked	O
coronary	O
artery	O
.	O

In	O
September	O
2017	O
the	O
US	location-GPE
FDA	organization-government,governmentagency
approved	O
its	O
use	O
for	O
``	O
adult	O
patients	O
who	O
have	O
hormone	other-biologything
receptor	other-biologything
(	O
HR	other-biologything
)	O
-positive	O
,	O
human	other-biologything
epidermal	other-biologything
growth	other-biologything
factor	other-biologything
receptor	other-biologything
2	other-biologything
(	O
HER2	other-biologything
)	O
-negative	O
advanced	O
or	O
metastatic	O
breast	other-disease
cancer	other-disease
that	O
has	O
progressed	O
after	O
taking	O
therapy	O
that	O
alters	O
a	O
patient	O
’	O
s	O
hormones	O
''	O
.	O

Use	O
of	O
these	O
drugs	O
has	O
been	O
associated	O
with	O
a	O
decrease	O
in	O
depression	other-disease
and	O
increased	O
functioning	O
in	O
social	O
and	O
work	O
environments	O
.	O

Second-generation	O
antipsychotics	O
,	O
including	O
risperidone	product-other
,	O
are	O
effective	O
in	O
the	O
treatment	O
of	O
manic	O
symptoms	O
in	O
acute	O
manic	other-disease
or	other-disease
mixed	other-disease
exacerbations	other-disease
of	O
bipolar	other-disease
disorder	other-disease
.	O

Additionally	O
,	O
research	O
suggests	O
that	O
confabulation	O
can	O
be	O
seen	O
in	O
patients	O
with	O
frontal	other-disease
lobe	other-disease
syndrome	other-disease
,	O
which	O
involves	O
an	O
insult	O
to	O
the	O
frontal	O
lobe	O
as	O
a	O
result	O
of	O
disease	O
or	O
traumatic	other-disease
brain	other-disease
injury	other-disease
(	O
TBI	other-disease
)	O
.	O

Penile	other-disease
dysmorphophobi	other-disease
a	O
is	O
related	O
to	O
body	other-disease
dysmorphic	other-disease
disorder	other-disease
(	O
BDD	other-disease
)	O
,	O
defined	O
by	O
the	O
Diagnostic	art-writtenart
and	art-writtenart
Statistical	art-writtenart
Manual	art-writtenart
of	art-writtenart
Mental	art-writtenart
Disorders-Fourth	art-writtenart
Edition	art-writtenart
(	O
Text	O
Revision	O
)	O
(	O
DSM-IV-TR	art-writtenart
)	O
as	O
a	O
condition	O
marked	O
by	O
excessive	O
preoccupation	O
with	O
an	O
imaginary	O
or	O
minor	O
defect	O
in	O
a	O
facial	O
feature	O
or	O
localized	O
part	O
of	O
the	O
body	O
.	O

Trichotillomania	other-disease
alone	O
is	O
believed	O
to	O
affect	O
10	O
million	O
people	O
in	O
the	O
United	location-GPE
States	location-GPE
.	O

World	event-attack,battle,war,militaryconflict
War	event-attack,battle,war,militaryconflict
I	event-attack,battle,war,militaryconflict
's	O
impact	O
on	O
colleges	O
in	O
the	O
country	O
,	O
and	O
the	O
Spanish	other-disease
flu	other-disease
pandemic	other-disease
of	O
1918	O
eliminated	O
most	O
of	O
that	O
year	O
's	O
scheduled	O
college	O
football	O
games	O
.	O

Primary	other-disease
progressive	other-disease
aphasia	other-disease
(	O
PPA	other-disease
)	O
is	O
a	O
syndrome	O
characterized	O
by	O
a	O
progressive	O
language	O
deficit	O
without	O
other	O
features	O
of	O
dementia	O
for	O
at	O
least	O
two	O
years	O
.	O

Vitamin	other-disease
C	other-disease
deficiency	other-disease
also	O
has	O
detrimental	O
effects	O
on	O
the	O
South	location-GPE
African	location-GPE
population	O
.	O

There	O
is	O
research	O
showing	O
that	O
in	O
people	O
with	O
gluten	other-disease
ataxia	other-disease
early	O
diagnosis	O
and	O
treatment	O
with	O
a	O
gluten	other-disease
-free	O
diet	O
can	O
improve	O
ataxia	O
and	O
prevent	O
its	O
progression	O
.	O

Herpes	other-disease
simplex	other-disease
virus	other-disease
1	other-disease
and	other-disease
2	other-disease
(	O
HSV	other-disease
1	other-disease
and	O
HSV	other-disease
2	other-disease
)	O
are	O
part	O
of	O
the	O
alpha	O
subfamily	O
of	O
HHVs	other-disease
.	O

Cystic	other-disease
fibrosis	other-disease
can	O
lead	O
to	O
infertility	O
in	O
men	O
.	O

Canine	other-biologything
chromosome	other-biologything
7	other-biologything
is	O
expressed	O
in	O
the	O
hippocampus	O
of	O
the	O
brain	O
,	O
the	O
same	O
area	O
that	O
Obsessive	other-disease
Compulsive	other-disease
Disorder	other-disease
is	O
expressed	O
in	O
human	O
patients	O
.	O

Behnke	O
separated	O
the	O
symptoms	O
of	O
Arterial	other-disease
Gas	other-disease
Embolism	other-disease
(	O
AGE	other-disease
)	O
from	O
those	O
of	O
decompression	O
sickness	O
and	O
suggested	O
the	O
use	O
of	O
oxygen	O
in	O
recompression	O
therapy	O
.	O

Hampton	person-artist,author
remained	O
active	O
until	O
a	O
stroke	other-disease
in	O
Paris	location-GPE
in	O
1991	O
led	O
to	O
a	O
collapse	O
on	O
stage	O
.	O

Between	O
10	O
%	O
and	O
30	O
%	O
of	O
adults	O
have	O
insomnia	other-disease
at	O
any	O
given	O
point	O
in	O
time	O
and	O
up	O
to	O
half	O
of	O
people	O
have	O
insomnia	other-disease
in	O
a	O
given	O
year	O
.	O

She	O
researched	O
on	O
various	O
topics	O
of	O
IVF	O
&	O
amp	O
;	O
Infertility	other-disease
during	O
her	O
specialization	O
.	O

Permanent	other-disease
junctional	other-disease
reciprocating	other-disease
tachycardia	other-disease
(	O
PJRT	other-disease
)	O
is	O
a	O
rare	O
cardiac	O
arrhythmia	O
.	O

On	O
6	O
May	O
2020	O
,	O
Eunice	person-other
moderated	O
an	O
online	O
webinar	O
for	O
Medecins	organization-other
Sans	organization-other
Frontieres	organization-other
or	O
Doctors	organization-other
without	organization-other
Borders	organization-other
titled	O
``	O
Live	O
Chat	O
on	O
COVID-19	other-disease
:	O
How	O
MSF	organization-other
Responds	O
to	O
a	O
Pandemic	O
''	O
.	O

Anemia	other-disease
is	O
a	O
medical	O
condition	O
that	O
arises	O
from	O
a	O
limited	O
intake	O
of	O
iron	other-chemicalthing
,	O
folic	other-chemicalthing
acid	other-chemicalthing
and	O
B12	other-chemicalthing
within	O
a	O
child	O
's	O
diet	O
.	O

Autoimmune	other-disease
polyendocrine	other-disease
syndrome	other-disease
type	other-disease
1	other-disease
is	O
inherited	O
in	O
an	O
autosomal	O
recessive	O
manner	O
.	O

In	O
Europe	location-GPE
,	O
they	O
are	O
particularly	O
threatened	O
by	O
crayfish	other-disease
plague	other-disease
,	O
which	O
is	O
caused	O
by	O
the	O
North	location-GPE
American	location-GPE
water	O
mold	O
``	O
Aphanomyces	other-disease
astaci	other-disease
.	other-disease
``	O

Peripheral	other-disease
neuropathy	other-disease
and	O
mononeuropathy	other-disease
can	O
be	O
a	O
result	O
of	O
a	O
variety	O
of	O
factors	O
,	O
but	O
are	O
a	O
result	O
of	O
one	O
of	O
three	O
methods	O
:	O

In	O
1998	O
,	O
Madredeus	person-artist,author
contributed	O
``	O
Os	art-music
Dias	art-music
São	art-music
A	art-music
Noite	art-music
(	O
Suso	person-artist,author
Saiz	person-artist,author
Remix	O
)	O
''	O
to	O
the	O
AIDS	other-disease
benefit	O
compilation	O
album	O
``	O
''	O
produced	O
by	O
the	O
Red	organization-company
Hot	organization-company
Organization	organization-company
.	O

In	O
April	O
2018	O
,	O
Levy	person-other
announced	O
that	O
he	O
had	O
Amyotrophic	other-disease
lateral	other-disease
sclerosis	other-disease
in	O
an	O
Op-Ed	O
arguing	O
for	O
educational	O
reforms	O
for	O
college	O
admissions	O
,	O
including	O
the	O
ending	O
of	O
legacy	O
admissions	O
and	O
increased	O
financial	O
aid	O
.	O

This	O
means	O
that	O
the	O
associated	O
tachycardia	O
may	O
be	O
subclinical	O
and	O
only	O
diagnosed	O
at	O
a	O
late	O
stage	O
,	O
after	O
significant	O
damage	O
to	O
the	O
heart	O
has	O
been	O
caused	O
from	O
prolonged	O
and	O
recurrent	O
episodes	O
of	O
AVRT	other-disease
.	O

Lingual	other-disease
thyroid	other-disease
may	O
be	O
asymptomatic	O
,	O
or	O
give	O
symptoms	O
such	O
as	O
dysphagia	O
(	O
difficulty	O
swallowing	O
)	O
,	O
dysphonia	O
(	O
difficulty	O
talking	O
)	O
and	O
dyspnea	O
(	O
difficulty	O
breathing	O
)	O
.	O

When	O
uric	other-chemicalthing
acid	other-chemicalthing
levels	O
and	O
gout	other-disease
symptoms	O
can	O
not	O
be	O
controlled	O
with	O
standard	O
gout	O
medicines	O
that	O
decrease	O
the	O
production	O
of	O
uric	other-chemicalthing
acid	other-chemicalthing
(	O
e.g.	O
,	O
allopurinol	other-chemicalthing
)	O
or	O
increase	O
uric	other-chemicalthing
acid	other-chemicalthing
elimination	O
from	O
the	O
body	O
through	O
the	O
kidneys	O
(	O
e.g.	O
,	O
probenecid	other-chemicalthing
)	O
,	O
this	O
can	O
be	O
referred	O
to	O
as	O
refractory	other-disease
chronic	other-disease
gout	other-disease
.	O

This	O
research	O
was	O
a	O
continuation	O
of	O
earlier	O
work	O
from	O
the	O
same	O
team	O
which	O
showed	O
that	O
replacing	O
the	O
α-methyl	O
group	O
of	O
MDMA	other-biologything
with	O
larger	O
aromatic	O
ring	O
systems	O
produced	O
compounds	O
which	O
lacked	O
psychoactivity	O
and	O
neurotoxicity	O
,	O
but	O
had	O
potent	O
anti-cancer	O
effects	O
against	O
Burkitt	other-disease
's	other-disease
lymphoma	other-disease
cells	O
``	O
in	O
vitro	O
''	O
.	O

Physical	O
effects	O
of	O
teratogens	other-disease
are	O
common	O
,	O
but	O
endocrine	O
effects	O
are	O
harder	O
to	O
measure	O
.	O

Jones	person-actor
is	O
prominently	O
featured	O
in	O
``	O
And	art-film
the	art-film
Band	art-film
Played	art-film
On	art-film
``	O
,	O
Randy	person-artist,author
Shilts	person-artist,author
's	O
best-selling	O
1987	O
work	O
of	O
non-fiction	O
about	O
the	O
AIDS	other-disease
epidemic	O
in	O
the	O
United	location-GPE
States	location-GPE
.	O

In	O
patients	O
with	O
AMS	other-disease
,	O
the	O
onset	O
of	O
HACE	other-disease
is	O
usually	O
indicated	O
by	O
vomiting	O
,	O
headache	O
that	O
does	O
not	O
respond	O
to	O
non-steroidal	O
anti-inflammatory	O
drugs	O
,	O
hallucinations	O
,	O
and	O
stupor	O
.	O

Use	O
of	O
the	O
term	O
``	O
Da	other-disease
Costa	other-disease
's	other-disease
syndrome	other-disease
``	O
peaked	O
in	O
the	O
early	O
20th	O
century	O
.	O

Cleve	person-other
Jones	person-other
(	O
born	O
October	O
11	O
,	O
1954	O
)	O
is	O
an	O
American	location-GPE
AIDS	other-disease
and	O
LGBT	O
rights	O
activist	O
.	O

It	O
was	O
1938	O
,	O
the	O
following	O
year	O
after	O
the	O
incident	O
,	O
when	O
he	O
was	O
finally	O
diagnosed	O
with	O
Myositis	other-disease
ossificans	other-disease
progressiva	other-disease
,	O
which	O
is	O
now	O
known	O
as	O
Fibrodysplasia	other-disease
Ossificans	other-disease
Progressiva	other-disease
(	O
FOP	other-disease
)	O
.	O

During	O
his	O
leadership	O
at	O
WHO	organization-other
he	O
notoriously	O
had	O
a	O
conflict	O
with	O
then	O
head	O
of	O
the	O
WHO	organization-other
's	O
Global	O
Programme	O
on	O
AIDS	other-disease
(	O
GPA	O
)	O
,	O
Jonathan	person-other
Mann	person-other
,	O
which	O
resulted	O
in	O
Mann	person-other
's	O
resignation	O
.	O

There	O
is	O
an	O
increased	O
risk	O
of	O
coronary	other-disease
heart	other-disease
disease	other-disease
.	O

Both	O
occupational	other-disease
asthma	other-disease
and	O
work-exacerbated	other-disease
asthma	other-disease
can	O
be	O
present	O
in	O
an	O
individual	O
.	O

Toxic	O
shock	O
and	O
sepsis	other-disease
may	O
occur	O
if	O
too	O
many	O
host	O
cells	O
undergo	O
pyroptosis	O
,	O
owing	O
to	O
either	O
overstimulation	O
of	O
the	O
immune	O
system	O
by	O
the	O
released	O
cytoplasmic	O
contents	O
or	O
to	O
host	O
cell	O
depletion	O
.	O

Marilee	person-artist,author
Shapiro	person-artist,author
Asher	person-artist,author
(	O
November	O
17	O
,	O
1912	O
–	O
September	O
11	O
,	O
2020	O
)	O
was	O
an	O
American	person-other
sculptor	O
,	O
author	O
and	O
survivor	O
of	O
both	O
the	O
Spanish	other-disease
Flu	other-disease
and	O
COVID-19	other-disease
.	O

In	O
May	O
2008	O
,	O
it	O
was	O
revealed	O
he	O
was	O
suffering	O
from	O
bone	O
cancer	other-disease
.	O

However	O
,	O
the	O
significance	O
of	O
GPC3	other-biologything
as	O
a	O
diagnostic	O
tool	O
for	O
human	O
tumors	O
other	O
than	O
HCC	other-disease
is	O
unclear	O
.	O

Hypervalinemia	other-disease
,	O
is	O
a	O
rare	O
autosomal	O
recessive	O
metabolic	O
disorder	O
in	O
which	O
urinary	O
and	O
serum	O
levels	O
of	O
the	O
branched-chain	other-biologything
amino	other-biologything
acid	other-biologything
valine	other-biologything
are	O
elevated	O
,	O
without	O
related	O
elevation	O
of	O
the	O
branched-chain	other-biologything
amino	other-biologything
acids	other-biologything
leucine	other-biologything
and	O
isoleucine	other-biologything
.	O

In	O
low-flow	O
(	O
ischemic	O
)	O
priapism	other-disease
the	O
flow	O
in	O
the	O
cavernous	other-biologything
arteries	other-biologything
is	O
reduced	O
or	O
absent	O
.	O

These	O
abnormalities	O
are	O
also	O
seen	O
as	O
symptoms	O
of	O
schizophrenia	other-disease
.	O

The	O
management	O
of	O
low	other-disease
back	other-disease
pain	other-disease
often	O
includes	O
medications	O
for	O
the	O
duration	O
that	O
they	O
are	O
beneficial	O
.	O

In	O
obstructive	other-disease
sleep	other-disease
apnea	other-disease
,	O
affected	O
individuals	O
are	O
categorized	O
based	O
on	O
how	O
many	O
apneas	O
or	O
hypopneas	O
(	O
apnea-hypopnea	O
index	O
or	O
AHI	O
)	O
or	O
events	O
they	O
have	O
per	O
hour	O
.	O

Chronic	O
phase	O
chronic	other-disease
myelogenous	other-disease
leukemia	other-disease
is	O
a	O
phase	O
of	O
chronic	other-disease
myelogenous	other-disease
leukemia	other-disease
in	O
which	O
5	O
%	O
or	O
fewer	O
of	O
the	O
cells	O
in	O
the	O
blood	O
and	O
bone	O
marrow	O
are	O
blast	O
cells	O
(	O
immature	O
blood	O
cells	O
)	O
.	O

It	O
reached	O
phase	O
II	O
clinical	O
trials	O
for	O
the	O
treatment	O
of	O
depression	other-disease
,	O
erectile	other-disease
dysfunction	other-disease
,	O
and	O
premature	other-disease
ejaculation	other-disease
prior	O
to	O
the	O
discontinuation	O
of	O
its	O
development	O
.	O

Perhaps	O
from	O
traders	O
,	O
the	O
cholera	other-disease
epidemic	O
reached	O
the	O
Plains	O
Indians	location-GPE
in	O
1849	O
,	O
resulting	O
in	O
severe	O
loss	O
of	O
life	O
during	O
the	O
summer	O
of	O
that	O
year	O
.	O

Separation	other-disease
anxiety	other-disease
disorder	other-disease
(	O
SepAD	other-disease
)	O
is	O
the	O
feeling	O
of	O
excessive	O
and	O
inappropriate	O
levels	O
of	O
anxiety	O
over	O
being	O
separated	O
from	O
a	O
person	O
or	O
place	O
.	O

On	O
19	O
December	O
2019	O
,	O
it	O
was	O
publicly	O
revealed	O
Burrow	person-other
had	O
been	O
diagnosed	O
with	O
Motor	other-disease
Neurone	other-disease
Disease	other-disease
(	O
MND	other-disease
)	O
.	O

Despite	O
their	O
local	O
infiltrative	O
and	O
aggressive	O
behavior	O
,	O
mortality	O
is	O
minimal	O
to	O
nonexistent	O
for	O
peripheral	other-disease
tumours	other-disease
.	O

Secondary	O
features	O
can	O
include	O
dementia	O
,	O
optic	O
atrophy	O
,	O
bilateral	O
deafness	O
,	O
peripheral	O
neuropathy	O
,	O
spasticity	O
,	O
multiple	O
lipomata	O
,	O
and/or	O
cardiomyopathy	O
with	O
Wolff	other-disease
Parkinson-White	other-disease
syndrome	O
.	O

The	O
World	organization-other
Health	organization-other
Organization	organization-other
classifies	O
Buruli	other-disease
ulcer	other-disease
into	O
three	O
categories	O
depending	O
on	O
the	O
severity	O
of	O
its	O
symptoms	O
.	O

Diminished	other-biologything
cerebral	other-biologything
glucose	other-biologything
metabolism	other-biologything
(	O
DCGM	other-biologything
)	O
may	O
not	O
be	O
solely	O
an	O
artifact	O
of	O
brain	other-biologything
cell	other-biologything
loss	O
since	O
it	O
occurs	O
in	O
asymptomatic	O
patients	O
at	O
risk	O
for	O
Alzheimer	other-disease
’	other-disease
s	other-disease
disease	other-disease
,	O
such	O
as	O
patients	O
homozygous	O
for	O
the	O
epsilon	other-biologything
4	other-biologything
variant	O
of	O
the	O
apolipoprotein	O
E	other-biologything
gene	other-biologything
(	O
APOE4	other-biologything
,	O
a	O
genetic	O
risk	O
factor	O
for	O
Alzheimer	other-disease
’	other-disease
s	other-disease
disease	other-disease
)	O
,	O
as	O
well	O
as	O
in	O
inherited	O
forms	O
of	O
Alzheimer	other-disease
’	other-disease
s	other-disease
disease	other-disease
.	O

US	location-GPE
First	O
case	O
of	O
canine	other-disease
zoonosis	other-disease
confirmed	O
.	O

Njølstad	other-disease
syndrom	other-disease
e	O
is	O
a	O
syndrome	O
characterized	O
by	O
non-immune	other-disease
hydrops	other-disease
fetalis	other-disease
(	O
NIHF	other-disease
)	O
,	O
congenital	other-disease
pulmonary	other-disease
lymphangiectasia	other-disease
(	O
CPL	other-disease
)	O
.	O

These	O
include	O
the	O
Child	other-disease
PTSD	other-disease
Symptom	other-disease
Scale	O
(	O
CPSS	O
)	O
,	O
Child	O
Trauma	O
Screening	O
Questionnaire	O
,	O
and	O
UCLA	organization-education
Post-traumatic	other-disease
Stress	other-disease
Disorder	other-disease
Reaction	O
Index	O
for	O
``	O
DSM-IV	O
''	O
.	O

In	O
addition	O
to	O
hemorrhagic	other-disease
cystitis	other-disease
,	O
temporary	O
hematuria	O
can	O
also	O
be	O
seen	O
in	O
bladder	O
infection	O
or	O
in	O
children	O
as	O
a	O
result	O
of	O
viral	O
infection	O
.	O

Alter	O
demonstrated	O
through	O
the	O
serologic	O
exclusion	O
of	O
Hepatitis	other-disease
A	other-disease
and	O
Hepatitis	other-disease
B	other-disease
that	O
a	O
third	O
,	O
previously	O
unrecognised	O
form	O
of	O
viral	O
hepatitis	O
existed	O
,	O
originally	O
named	O
non-A	other-disease
,	other-disease
non-B	other-disease
hepatitis	other-disease
(	O
NANBH	other-disease
)	O
.	O

Myasthenia	other-disease
gravis	other-disease
is	O
an	O
autoimmune	O
disease	O
,	O
where	O
the	O
body	O
produces	O
antibodies	other-biologything
targeted	other-biologything
against	O
the	O
acetylcholine	other-biologything
receptor	other-biologything
on	O
the	O
postsynaptic	other-biologything
membrane	other-biologything
in	O
the	O
neuromuscular	other-biologything
junction	other-biologything
.	O

HACE	other-disease
must	O
be	O
distinguished	O
from	O
conditions	O
with	O
similar	O
symptoms	O
,	O
including	O
stroke	O
,	O
intoxication	O
,	O
psychosis	O
,	O
diabetic	O
symptoms	O
,	O
meningitis	O
,	O
or	O
ingestion	O
of	O
toxic	O
substances	O
.	O

In	O
2020	O
,	O
the	O
bucket	O
was	O
widely	O
used	O
in	O
the	O
African	location-GPE
continent	O
and	O
the	O
global	O
community	O
to	O
fight	O
the	O
novel	O
pandemic	O
Coronavirus	other-disease
(	O
COVID-19	other-disease
)	O
or	O
SARS-COV-2	other-disease
.	O

Subtypes	O
of	O
schizophrenia	other-disease
are	O
no	O
longer	O
recognized	O
as	O
separate	O
conditions	O
from	O
schizophrenia	other-disease
by	O
DSM-5	art-writtenart
or	O
ICD-11	art-writtenart
.	O

Common	O
conditions	O
that	O
reduce	O
serum	other-biologything
albumin	other-biologything
in	O
the	O
clinical	O
setting	O
are	O
hemorrhage	other-disease
,	O
nephrotic	other-disease
syndrome	other-disease
,	O
intestinal	other-disease
obstruction	other-disease
and	O
liver	other-disease
cirrhosis	other-disease
.	O

In	O
kidney	other-disease
cancer	other-disease
,	O
this	O
effect	O
could	O
be	O
due	O
to	O
the	O
presence	O
of	O
mutations	O
in	O
the	O
von	other-biologything
Hippel–Lindau	other-biologything
tumor	other-biologything
suppressor	O
gene	O
upregulating	O
glycolytic	O
enzymes	O
,	O
including	O
the	O
M2	other-biologything
splice	other-biologything
isoform	other-biologything
of	O
pyruvate	other-biologything
kinase	other-biologything
.	O

It	O
is	O
used	O
for	O
treatment	O
of	O
acute	other-disease
lymphoblastic	other-disease
leukemia	other-disease
and	O
Chronic	other-disease
myelogenous	other-disease
leukemia	other-disease
in	O
blast	other-disease
crisis	other-disease
.	O

Scurvy	other-disease
,	O
a	O
disease	O
that	O
develops	O
from	O
an	O
extended	O
shortage	O
of	O
Vitamin	other-biologything
C	other-biologything
,	O
has	O
previously	O
been	O
found	O
prevalent	O
in	O
certain	O
South	location-GPE
African	location-GPE
mining	O
populations	O
.	O

The	O
three	O
diseases	O
are	O
classified	O
together	O
as	O
the	O
GM2	other-disease
gangliosidoses	O
,	O
because	O
each	O
disease	O
represents	O
a	O
distinct	O
molecular	O
point	O
of	O
failure	O
in	O
the	O
activation	O
of	O
the	O
same	O
enzyme	O
,	O
beta-hexosaminidase	O
.	O

Aortic	O
valve	O
replacement	O
using	O
conventional	O
cryopreserved	O
homografts	O
is	O
currently	O
performed	O
only	O
in	O
about	O
3	O
%	O
of	O
all	O
patients	O
,	O
mostly	O
to	O
treat	O
acute	other-disease
aortic	other-disease
valve	other-disease
endocarditis.1	other-disease
Severe	O
calcification	O
of	O
conventional	O
homografts	O
frequently	O
occurs	O
and	O
is	O
the	O
main	O
reason	O
for	O
its	O
restrictive	O
use	O
,	O
however	O
,	O
current	O
guidelines	O
confirm	O
homografts	O
as	O
a	O
valid	O
alternative	O
for	O
young	O
patients	O
requiring	O
anatomical	O
reconstruction	O
of	O
the	O
outflow	O
tract	O
.	O

It	O
offers	O
potential	O
as	O
a	O
new	O
class	O
of	O
oral	O
direct-acting	O
antiviral	O
drug	O
for	O
Hepatitis	other-disease
C	other-disease
that	O
may	O
be	O
used	O
in	O
combination	O
with	O
either	O
current	O
treatment	O
strategies	O
or	O
with	O
new	O
classes	O
of	O
direct-acting	O
antiviral	O
drugs	O
in	O
development	O
.	O

On	O
the	O
evening	O
of	O
November	O
2	O
,	O
2008	O
,	O
in	O
North	location-GPE
Las	location-GPE
Vegas	location-GPE
,	O
Nevada	location-GPE
,	O
Tolbert	person-other
suffered	O
a	O
heart	other-disease
attack	other-disease
while	O
driving	O
alone	O
near	O
the	O
Obama	person-politician
campaign	O
offices	O
.	O

Those	O
with	O
Autism	other-disease
Spectrum	other-disease
Disorder	other-disease
(	O
ASD	other-disease
)	O
can	O
have	O
hyperacusis	other-disease
,	O
which	O
is	O
an	O
abnormal	O
sensitivity	O
to	O
sound	O
.	O

Some	O
examples	O
of	O
behavioral	O
disorders	O
include	O
anxiety	other-disease
,	O
alcohol	other-disease
dependence	other-disease
,	O
and	O
drug	O
use	O
.	O

Before	O
2013	O
,	O
the	O
subtypes	O
of	O
schizophrenia	other-disease
were	O
classified	O
as	O
paranoid	O
,	O
disorganized	O
,	O
catatonic	O
,	O
undifferentiated	O
,	O
and	O
residual	O
type	O
.	O

These	O
results	O
suggests	O
that	O
loss	O
of	O
function	O
mutations	O
or	O
decreased	O
expression	O
of	O
MIAT	other-biologything
is	O
involved	O
in	O
driving	O
aberrant	O
cortical	O
splicing	O
patterns	O
observed	O
in	O
SZ	other-disease
post-mortem	O
brains	O
.	O

An	O
epidural	O
blood	O
patch	O
is	O
the	O
typical	O
treatment	O
for	O
a	O
CSF	other-disease
leak	other-disease
,	O
where	O
up	O
to	O
20	O
cubic	O
centimeters	O
of	O
the	O
patient	O
's	O
blood	O
is	O
drawn	O
,	O
then	O
injected	O
into	O
either	O
the	O
lumbar	O
or	O
cervical	O
spine	O
,	O
close	O
to	O
the	O
known	O
or	O
suspected	O
site	O
of	O
the	O
leak	O
.	O

While	O
the	O
exact	O
cause	O
of	O
pre-eclampsia	other-disease
remains	O
unclear	O
,	O
there	O
is	O
strong	O
evidence	O
that	O
a	O
major	O
cause	O
predisposing	O
a	O
susceptible	O
woman	O
to	O
pre-eclampsia	other-disease
is	O
an	O
abnormally	O
implanted	O
placenta	O
.	O

The	O
Tygerberg	O
scoring	O
system	O
helps	O
the	O
clinician	O
to	O
decide	O
whether	O
pericarditis	O
is	O
due	O
to	O
tuberculosis	O
or	O
whether	O
it	O
is	O
due	O
to	O
another	O
cause	O
:	O
night	O
sweats	O
(	O
1	O
point	O
)	O
,	O
weight	O
loss	O
(	O
1	O
point	O
)	O
,	O
fever	O
(	O
2	O
point	O
)	O
,	O
serum	O
globulin	O
&	O
gt	O
;	O
40g/l	O
(	O
3	O
points	O
)	O
,	O
blood	O
total	O
leucocyte	O
count	O
&	O
lt	O
;	O
10	O
x	O
109/l	O
(	O
3	O
points	O
)	O
;	O
a	O
total	O
score	O
of	O
6	O
or	O
more	O
is	O
highly	O
suggestive	O
of	O
tuberculous	other-disease
pericarditis	other-disease
.	O

AIDS	other-disease
is	O
defined	O
as	O
the	O
clinical	O
stage	O
IV	O
of	O
the	O
HIV	other-biologything
infection	O
.	O

The	O
formation	O
of	O
coronary	other-disease
thrombosis	other-disease
generally	O
follows	O
the	O
same	O
mechanism	O
as	O
other	O
blood	O
clots	O
in	O
the	O
body	O
,	O
the	O
coagulation	O
cascade	O
.	O

In	O
2000	O
,	O
NAMRU-3	organization-other
successfully	O
investigated	O
the	O
first	O
outbreak	O
of	O
Rift	other-disease
Valley	other-disease
fever	other-disease
outside	O
Africa	location-GPE
in	O
Yemen	location-GPE
.	O

CD36	other-biologything
interacts	O
with	O
a	O
number	O
of	O
ligands	O
,	O
including	O
collagen	other-biologything
types	other-biologything
I	other-biologything
and	O
IV	O
,	O
thrombospondin	O
,	O
erythrocytes	O
parasitized	O
with	O
``	O
Plasmodium	other-disease
falciparum	other-disease
``	O
,	O
platelet-agglutinating	other-biologything
protein	other-biologything
p37	other-biologything
,	O
oxidized	other-biologything
low	other-biologything
density	other-biologything
lipoprotein	other-biologything
and	O
long-chain	other-biologything
fatty	other-biologything
acids	other-biologything
.	O

Potential	O
applications	O
for	O
this	O
research	O
include	O
blood	O
glucose	O
monitoring	O
systems	O
to	O
help	O
manage	O
diabetes	other-disease
mellitus	other-disease
.	O

Disruptions	O
in	O
the	O
plantar	O
fascia	O
's	O
normal	O
mechanical	O
movement	O
during	O
standing	O
and	O
walking	O
(	O
known	O
as	O
the	O
Windlass	O
mechanism	O
)	O
place	O
excess	O
strain	O
on	O
the	O
calcaneal	O
tuberosity	O
and	O
seem	O
to	O
contribute	O
to	O
the	O
development	O
of	O
plantar	other-disease
fasciitis	other-disease
.	O

Treatments	O
are	O
not	O
always	O
successful	O
,	O
especially	O
when	O
the	O
cause	O
of	O
POIS	other-disease
in	O
a	O
particular	O
patient	O
has	O
not	O
been	O
determined	O
.	O

The	O
regiment	O
fought	O
under	O
General	O
Sir	O
John	person-soldier
Moore	person-soldier
in	O
the	O
retreat	O
to	O
Corunna	location-GPE
,	O
and	O
on	O
returning	O
to	O
England	location-GPE
they	O
were	O
part	O
of	O
the	O
Walcheren	event-attack,battle,war,militaryconflict
Campaign	event-attack,battle,war,militaryconflict
in	O
the	O
Netherlands	location-GPE
where	O
many	O
were	O
struck	O
down	O
with	O
malaria	other-disease
.	O

People	O
can	O
develop	O
permanent	O
disabilities	O
including	O
``	O
cognitive	other-disease
deficits	other-disease
,	O
ataxia	other-disease
,	O
hemiparesis	other-disease
,	O
blindness	other-disease
,	O
deafness	other-disease
,	O
or	O
amputation	other-disease
following	other-disease
gangrene	other-disease
``	O
.	O

By	O
1975	O
,	O
resulting	O
from	O
several	O
serious	O
injuries	O
that	O
led	O
to	O
hospitalization	O
in	O
the	O
intensive	O
care	O
unit	O
,	O
Salvatore	person-other
was	O
cured	O
of	O
his	O
impulse	other-disease
control	other-disease
disorder	other-disease
that	O
was	O
the	O
root	O
cause	O
of	O
his	O
addiction	O
to	O
high	O
speed	O
.	O

Polycythemia	other-disease
is	O
sometimes	O
called	O
erythrocytosis	other-disease
,	O
but	O
the	O
terms	O
are	O
not	O
synonymous	O
,	O
because	O
polycythemia	other-disease
refers	O
to	O
any	O
increase	O
in	O
red	O
blood	O
mass	O
(	O
due	O
to	O
an	O
erythrocytosis	O
or	O
not	O
)	O
,	O
whereas	O
erythrocytosis	other-disease
only	O
refers	O
to	O
a	O
documented	O
increase	O
of	O
red	O
cell	O
count	O
.	O

Growth	other-disease
hormone	other-disease
deficiency	other-disease
has	O
been	O
reported	O
in	O
several	O
individuals	O
with	O
18p-	O
,	O
though	O
not	O
at	O
the	O
same	O
frequency	O
as	O
in	O
the	O
distal	O
18q-	O
population	O
.	O

Buruli	other-disease
ulcers	other-disease
can	O
appear	O
anywhere	O
on	O
the	O
body	O
,	O
but	O
are	O
typically	O
on	O
the	O
limbs	O
.	O

BPH	other-disease
is	O
a	O
result	O
of	O
the	O
ongoing	O
process	O
of	O
testosterone	other-biologything
being	O
converted	O
to	O
dihydrotestosterone	other-biologything
which	O
stimulates	O
prostate	O
growth	O
.	O

The	O
Panic	O
and	O
Agoraphobia	O
Scale	O
(	O
PAS	O
)	O
is	O
a	O
rating	O
scale	O
developed	O
for	O
measuring	O
severity	O
of	O
agoraphobia	other-disease
with	O
or	O
without	O
panic	O
attacks	O
.	O

Ecury	person-other
died	O
on	O
2	O
March	O
2012	O
in	O
Willemstad	location-GPE
,	O
after	O
a	O
five	O
year	O
struggle	O
with	O
Alzheimer	other-disease
’	O
s	O
disease	O
.	O

Many	O
people	O
with	O
personality	O
disorders	O
,	O
potentially	O
caused	O
or	O
made	O
worse	O
by	O
dysfunctional	O
upbringing	O
,	O
especially	O
Borderline	other-disease
Personality	other-disease
Disorder	other-disease
(	O
BPD	other-disease
)	O
and	O
some	O
others	O
,	O
perpetually	O
vascilate	O
between	O
the	O
poles	O
of	O
the	O
dialectic	O
conflict	O
,	O
with	O
resulting	O
instability	O
causing	O
problems	O
in	O
living	O
that	O
are	O
not	O
mediated	O
by	O
other	O
therapy	O
modalities	O
.	O

mTOR	other-biologything
inhibitors	O
are	O
effective	O
at	O
shrinking	O
the	O
size	O
of	O
lymphangioleiomyomatosis	other-disease
,	O
and	O
can	O
lead	O
to	O
total	O
resolution	O
.	O

They	O
can	O
reduce	O
inflammation	O
and	O
histamine	O
production	O
in	O
the	O
nasal	O
passages	O
,	O
and	O
have	O
been	O
shown	O
to	O
relieve	O
nasal	other-disease
congestion	other-disease
,	O
runny	other-disease
nose	other-disease
,	O
itchy	other-disease
nose	other-disease
and	O
sneezing	other-disease
.	O

Olfactory	O
dysfunction	O
(	O
loss	O
of	O
sense	O
of	O
smell	O
)	O
is	O
common	O
in	O
Parkinson	other-disease
’	O
s	O
disease	O
,	O
and	O
has	O
also	O
been	O
reported	O
to	O
occur	O
in	O
patients	O
with	O
essential	O
tremor	O
.	O

Gouty	other-disease
arthritis	other-disease
can	O
become	O
particularly	O
painful	O
and	O
potentially	O
debilitating	O
when	O
gout	O
can	O
not	O
successfully	O
be	O
treated	O
.	O

People	O
with	O
ASD	other-disease
who	O
experience	O
hyperacusis	other-disease
may	O
have	O
unpleasant	O
emotions	O
,	O
such	O
as	O
fear	O
and	O
anxiety	O
,	O
and	O
uncomfortable	O
physical	O
sensations	O
in	O
noisy	O
environments	O
with	O
loud	O
sounds	O
.	O

Under	O
the	O
directorships	O
of	O
Mullan	person-other
and	O
Crawford	person-other
the	O
Roskamp	organization-other
Institute	organization-other
focuses	O
on	O
discovering	O
new	O
treatments	O
for	O
Alzheimer	other-disease
's	O
disease	O
,	O
traumatic	other-disease
brain	other-disease
injury	other-disease
,	O
multiple	other-disease
sclerosis	other-disease
,	O
Gulf	O
War	O
illness	O

Allergies	other-disease
,	O
exposure	O
to	O
environmental	O
irritants	O
,	O
or	O
a	O
persistent	O
inflammation	O
within	O
the	O
sinuses	O
can	O
lead	O
to	O
turbinate	other-disease
swelling	other-disease
.	O

Jacksonian	other-disease
march	other-disease
or	O
Jacksonian	other-disease
seizure	other-disease
is	O
a	O
phenomenon	O
where	O
a	O
simple	O
partial	O
seizure	O
spreads	O
from	O
the	O
distal	O
part	O
of	O
the	O
limb	O
toward	O
the	O
ipsilateral	O
face	O
(	O
on	O
same	O
side	O
of	O
body	O
)	O
.	O

LAL	other-disease
Deficiency	other-disease
affects	O
patients	O
of	O
all	O
ages	O
with	O
sudden	O
and	O
unpredictable	O
clinical	O
complications	O
manifesting	O
from	O
infancy	O
through	O
adulthood	O
.	O

Hemoglobin	other-biologything
analysis	O
is	O
important	O
for	O
the	O
diagnosis	O
of	O
alpha-thalassemia	other-disease
as	O
it	O
determines	O
the	O
types	O
and	O
percentages	O
of	O
types	O
of	O
hemoglobin	other-biologything
present	O
.	O

It	O
is	O
also	O
used	O
in	O
Pulmonary	other-disease
Aspergillosis	other-disease
in	O
a	O
dry	O
powder	O
inhalation	O
system	O
.	O

Most	O
people	O
with	O
CAD	other-disease
have	O
symptoms	O
of	O
hemolytic	other-disease
anemia	other-disease
(	O
destruction	O
of	O
red	other-biologything
blood	other-biologything
cells	other-biologything
,	O
causing	O
low	O
levels	O
of	O
red	other-biologything
blood	other-biologything
cells	other-biologything
)	O
.	O

If	O
a	O
hemoglobin	other-biologything
tests	O
shows	O
that	O
a	O
person	O
's	O
levels	O
are	O
below	O
normal	O
,	O
it	O
means	O
they	O
have	O
a	O
low	O
red	O
blood	O
cell	O
count	O
,	O
which	O
is	O
known	O
as	O
anemia	other-disease
.	O

In	O
2005	O
,	O
a	O
field	O
evaluation	O
of	O
a	O
novel	O
handheld	O
microscope	O
was	O
undertaken	O
in	O
Uganda	location-GPE
for	O
the	O
diagnosis	O
of	O
intestinal	other-disease
schistosomiasis	other-disease
by	O
a	O
team	O
led	O
by	O
Russell	person-other
Stothard	person-other
from	O
the	O
Natural	building-other
History	building-other
Museum	building-other
of	O
London	location-GPE
,	O
working	O
with	O
the	O
Schistosomiasis	organization-other
Control	organization-other
Initiative	organization-other
,	O
London	location-GPE
.	O

Williams	person-other
was	O
diagnosed	O
with	O
Attention	other-disease
deficit	other-disease
hyperactivity	other-disease
disorder	other-disease
(	O
ADHD	other-disease
)	O
and	O
Tourette	other-disease
syndrome	other-disease
as	O
a	O
child	O
.	O

Wallace	person-other
died	O
from	O
pneumonia	other-disease
and	O
sepsis	other-disease
on	O
October	O
25	O
,	O
2013	O
,	O
aged	O
70	O
,	O
a	O
week	O
before	O
her	O
71st	O
birthday	O
.	O

Four	O
deaths	O
were	O
registered	O
in	O
the	O
official	O
adverse	O
event	O
register	O
,	O
and	O
while	O
in	O
only	O
two	O
cases	O
a	O
clear	O
causal	O
link	O
was	O
considered	O
to	O
be	O
in	O
place	O
,	O
two	O
other	O
cases	O
were	O
diagnosed	O
with	O
a	O
disease	O
which	O
in	O
scientific	O
peer-reviewed	O
articles	O
(	O
case	O
descriptions	O
)	O
have	O
been	O
mistakenly	O
first	O
made	O
,	O
and	O
afterward	O
have	O
been	O
noticed	O
to	O
be	O
disseminated	O
BCG	other-disease
infections	other-disease
.	O

Approximately	O
1	O
%	O
of	O
those	O
whose	O
CNS	other-biologything
is	O
affected	O
die	O
from	O
mumps	other-disease
.	O

Initial	O
orthostatic	other-disease
hypotension	other-disease
is	O
frequently	O
characterized	O
by	O
a	O
systolic	O
blood	O
pressure	O
decrease	O
of	O
≥40	O
mmHg	O
or	O
diastolic	O
blood	O
pressure	O
decrease	O
of	O
≥20	O
mmHg	O
within	O
15	O
seconds	O
of	O
standing	O
.	O

Several	O
causes	O
have	O
been	O
speculated	O
,	O
including	O
a	O
capillary	other-disease
leak	other-disease
syndrome	other-disease
from	O
cytokine	O
release	O
from	O
the	O
differentiating	O
myeloid	other-biologything
cells	other-biologything
.	O

Is	O
estimated	O
that	O
only	O
5–14	O
%	O
of	O
patients	O
with	O
WE	other-disease
are	O
diagnosed	O
in	O
life	O
.	O

Mesulam	person-scholar
's	O
original	O
description	O
in	O
1982	O
of	O
progressive	O
language	O
problems	O
caused	O
by	O
neurodegenerative	other-disease
disease	other-disease
(	O
which	O
he	O
called	O
primary	other-disease
progressive	other-disease
aphasia	other-disease
(	O
PPA	other-disease
)	O
included	O
patients	O
with	O
progressive	O
nonfluent	O
(	O
aphasia	other-disease
,	O
semantic	other-disease
dementia	other-disease
,	O
and	O
logopenic	other-disease
progressive	other-disease
aphasia	other-disease
.	O

Other	O
studies	O
demonstrate	O
differential	O
expression	O
of	O
Papillary	other-disease
Thyroid	other-disease
cancer	O
and	O
Estrogen	other-biologything
Receptor	other-biologything
alpha-silenced	O
MCF7	other-biologything
breast	O
cancer	O
cells	O
.	O

The	O
unproven	O
health	O
benefits	O
attributed	O
to	O
yogurt	O
that	O
were	O
previously	O
posted	O
on	O
the	O
walls	O
of	O
Pinkberry	O
(	O
e.g.	O
,	O
cures	O
colon	other-disease
cancer	other-disease
,	O
fights	O
yeast	O
infections	O
)	O
have	O
been	O
removed	O
.	O

These	O
partners	O
include	O
the	organization-other
Greater	organization-other
Boston	organization-other
YMCA	organization-other
,	O
Bird	organization-other
Street	organization-other
Community	organization-other
Center	organization-other
,	O
the	O
Watertown	organization-other
Boys	organization-other
and	organization-other
Girls	organization-other
Clu	organization-other
b	O
,	O
and	O
Mass	product-other
General	product-other
Hospital	product-other
's	product-other
Aspire	product-other
program	product-other
for	O
children	O
with	O
Asperger	other-disease
's	other-disease
syndrome	other-disease
.	O

Folic	O
acid	O
deficiency	O
is	O
a	O
common	O
association	O
of	O
nutritional	other-disease
anemia	other-disease
and	O
iron	other-disease
deficiency	other-disease
anemia	other-disease
is	O
the	O
most	O
common	O
nutritional	O
disorder	O
.	O

Other	O
angiogenesis	O
inhibitors	O
are	O
also	O
being	O
investigated	O
as	O
potential	O
ovarian	other-disease
cancer	other-disease
treatments	O
.	O

Thus	O
,	O
diarrhea	other-disease
can	O
be	O
categorized	O
into	O
secretory	other-disease
diarrhea	other-disease
,	O
an	O
excess	other-disease
of	other-disease
secretion	other-disease
,	O
or	O
osmotic	other-disease
diarrhea	other-disease
which	O
is	O
a	O
lack	O
of	O
absorption	O
.	O

Compartment	other-disease
syndrome	other-disease
is	O
a	O
condition	O
in	O
which	O
increased	O
pressure	O
within	O
one	O
of	O
the	O
body	O
's	O
anatomical	O
compartments	O
results	O
in	O
insufficient	O
blood	O
supply	O
to	O
tissue	O
within	O
that	O
space	O
.	O

Oral	O
iron	other-chemicalthing
supplementations	O
are	O
the	O
first	O
line	O
of	O
care	O
for	O
iron	other-disease
deficiency	other-disease
and	O
iron	other-disease
deficiency	other-disease
anaemia	other-disease
.	O

Lymphoedema	other-disease
may	O
develop	O
in	O
many	O
cases	O
accompanied	O
by	O
acral	O
thickening	O
of	O
the	O
skin	O
folds	O
,	O
hyperkeratosis	other-disease
and	O
papillomatosis	other-disease
.	O

The	O
study	O
found	O
that	O
36	O
percent	O
of	O
the	O
cancer	O
patients	O
had	O
HPV	other-disease
compared	O
to	O
only	O
1	O
percent	O
of	O
the	O
healthy	O
control	O
group	O
.	O

In	O
2013	O
,	O
a	O
study	O
revealed	O
that	O
1	O
in	O
2,000	O
people	O
in	O
the	O
United	location-GPE
Kingdom	location-GPE
might	O
harbour	O
the	O
infectious	O
prion	O
protein	O
that	O
causes	O
vCJD	other-disease
.	O

With	O
the	O
first	O
episode	O
of	O
low	other-disease
back	other-disease
pain	other-disease
the	O
hope	O
is	O
a	O
complete	O
cure	O
;	O
however	O
,	O
if	O
the	O
problem	O
becomes	O
chronic	O
,	O
the	O
goals	O
may	O
change	O
to	O
pain	O
management	O
and	O
the	O
recovery	O
of	O
as	O
much	O
function	O
as	O
possible	O
.	O

This	O
led	O
to	O
a	O
corresponding	O
increase	O
in	O
gene	O
expression	O
,	O
which	O
was	O
similar	O
to	O
the	O
increased	O
histone	O
lysine	O
acetylation	O
at	O
these	O
gene	O
promoters	O
in	O
type	other-disease
1	other-disease
diabetes	other-disease
and	O
type	other-disease
2	other-disease
diabetes	other-disease
patients	O
compared	O
to	O
healthy	O
control	O
volunteers	O
.	O

Besides	O
its	O
cosmetic	O
application	O
,	O
Botox	other-biologything
is	O
used	O
in	O
the	O
treatment	O
of	O
other	O
conditions	O
including	O
migraine	other-disease
headache	other-disease
and	O
cervical	other-disease
dystonia	other-disease
(	O
spasmodic	other-disease
torticollis	other-disease
)	O
(	O
a	O
neuromuscular	O
disorder	O
involving	O
the	O
head	O
and	O
neck	O
)	O
.	O

In	O
1993	O
,	O
an	O
outbreak	O
of	O
HCPS	other-disease
,	O
then	O
unrecognized	O
,	O
occurred	O
in	O
the	O
Four	location-GPE
Corners	location-GPE
region	O
of	O
the	O
United	location-GPE
States	location-GPE
and	O
led	O
to	O
the	O
discovery	O
of	O
the	O
``	O
Sin	other-biologything
Nombre	other-biologything
orthohantavirus	other-biologything
``	O
.	O

Nausea	other-disease
and	O
vomiting	other-disease
may	O
be	O
initiated	O
by	O
various	O
stimuli	O
,	O
through	O
different	O
neuronal	O
pathways	O
.	O

The	O
precipitating	O
infections	O
that	O
may	O
lead	O
to	O
septic	O
shock	O
if	O
severe	O
enough	O
include	O
but	O
are	O
not	O
limited	O
to	O
appendicitis	other-disease
,	O
pneumonia	other-disease
,	O
bacteremia	other-disease
,	O
diverticulitis	other-disease
,	O
pyelonephritis	other-disease
,	O
meningitis	other-disease
,	O
pancreatitis	other-disease
,	O
necrotizing	other-disease
fasciitis	other-disease
,	O
MRSA	other-disease
and	O
mesenteric	other-disease
ischemia	other-disease
.	O

She	O
was	O
described	O
as	O
physically	O
unattractive	O
and	O
was	O
(	O
by	O
the	O
standard	O
of	O
medicine	O
of	O
that	O
time	O
)	O
infertile	O
from	O
Basedow	other-disease
syndrome	other-disease
.	O

The	O
hereditary	O
conditions	O
–	O
Marfan	other-disease
syndrome	other-disease
,	O
homocystinuria	other-disease
,	O
Ehlers–Danlos	other-disease
syndromes	other-disease
,	O
alpha	other-disease
1-antitrypsin	other-disease
deficiency	other-disease
(	O
which	O
leads	O
to	O
emphysema	other-disease
)	O
,	O
and	O
Birt–Hogg–Dubé	other-disease
syndrome	other-disease
–	O
have	O
all	O
been	O
linked	O
to	O
familial	O
pneumothorax	other-disease
.	O

Suppression	O
of	O
HIV	other-disease
with	O
antiretroviral	O
medications	O
,	O
careful	O
monitoring	O
of	O
immunosuppressive	O
medications	O
are	O
important	O
means	O
of	O
prevention	O
.	O

DNA	other-biologything
testing	O
is	O
now	O
the	O
preferred	O
method	O
of	O
establishing	O
a	O
diagnosis	O
for	O
MEN	other-disease
2B	other-disease
,	O
and	O
is	O
thought	O
to	O
be	O
almost	O
100	O
%	O
sensitive	O
and	O
specific	O
.	O

Vaccinating	O
girls	O
with	O
HPV	O
vaccine	O
before	O
their	O
initial	O
sexual	O
contact	O
has	O
been	O
claimed	O
to	O
reduce	O
incidence	O
of	O
VIN	other-disease
.	O

During	O
Elvira	person-other
's	O
tenure	O
at	O
Frost	organization-other
Bank	organization-other
,	O
she	O
spent	O
her	O
evenings	O
at	O
nearby	O
Santa	building-other
Rosa	building-other
Hospital	building-other
caring	O
for	O
her	O
younger	O
brother	O
,	O
Henry	person-other
,	O
who	O
wound	O
up	O
passing	O
away	O
from	O
Hodgkins	other-disease
disease	other-disease
in	O
1943	O
,	O
at	O
age	O
14	O
.	O

In	O
the	O
late	O
1990s	O
,	O
Helm	person-artist,author
was	O
diagnosed	O
with	O
throat	other-disease
cancer	other-disease
after	O
suffering	O
hoarseness	O
.	O

They	O
discussed	O
organizing	O
a	O
new	O
campaign	O
to	O
retake	O
Missouri	location-GPE
,	O
but	O
Jackson	person-soldier
died	O
of	O
pneumonia	other-disease
and	O
stomach	other-disease
cancer	other-disease
before	O
such	O
actions	O
took	O
place	O
.	O

Orkin	person-scholar
has	O
been	O
involved	O
with	O
several	O
initiatives	O
to	O
increase	O
testing	O
rates	O
of	O
HIV	other-disease
/	O
AIDS	other-disease
,	O
and	O
in	O
2015	O
she	O
launched	O
``	O
Going	event-other
Viral	event-other
``	O
,	O
a	O
week	O
to	O
raise	O
awareness	O
of	O
blood-borne	O
viruses	O
.	O

Between	O
1999	O
and	O
2009	O
,	O
Berra	person-scholar
worked	O
in	O
various	O
pharmaceutical	O
laboratories	O
around	O
Lyon	location-GPE
,	O
including	O
Boehringer	organization-company
Ingelheim	organization-company
(	O
1999-2001	O
)	O
and	O
Bristol	organization-company
Myers	organization-company
Squibb	organization-company
(	O
2001-2006	O
)	O
,	O
where	O
she	O
conducted	O
research	O
on	O
cervical	other-disease
cancer	other-disease
and	O
Hepatitis	other-disease
B	other-disease
.	O

On	O
the	O
one	O
hand	O
,	O
lipodystrophy	other-disease
seems	O
to	O
be	O
mainly	O
due	O
to	O
HIV-1	other-biologything
protease	other-biologything
inhibitors	O
.	O

to	O
be	O
differentiated	O
from	O
colonic	other-disease
cutoff	other-disease
sign	other-disease
which	O
is	O
a	O
dilatation	O
of	O
a	O
segment	O
of	O
large	O
bowel	O
.	O

Australian	location-GPE
astrophysicist	O
Rodney	person-scholar
Marks	person-scholar
had	O
Tourette	other-disease
syndrome	O
.	O

It	O
causes	O
profound	O
amnesia	other-disease
but	O
allows	O
spontaneous	O
respiration	O
,	O
cardiopulmonary	O
stability	O
,	O
and	O
airway	O
reflexes	O
are	O
still	O
intact	O
.	O

In	O
1987–1994	O
,	O
there	O
were	O
no	O
subtypes	O
and	O
thus	O
it	O
was	O
not	O
distinguished	O
from	O
hyperactive	O
ADHD	other-disease
in	O
the	O
Diagnostic	O
and	O
Statistical	O
Manual	O
(	O
DSM-III-R	O
)	O
.	O

They	O
can	O
go	O
through	O
computed	O
tomography	O
(	O
CT	O
)	O
or	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
.The	O
classification	O
for	O
the	O
severity	O
of	O
MERRF	other-disease
syndrome	O
is	O
difficult	O
to	O
distinguish	O
since	O
most	O
individuals	O
will	O
exhibit	O
multi-symptoms	O
.	O

Said	O
organization	O
stated	O
that	O
excluding	O
marginalised	O
groups	O
would	O
compromise	O
efforts	O
to	O
stop	O
the	O
spread	O
of	O
AIDS	other-disease
in	O
Uganda	location-GPE
,	O
a	O
social	O
problem	O
to	O
the	O
point	O
that	O
a	O
full	O
5.4	O
%	O
of	O
the	O
adult	O
population	O
had	O
been	O
infected	O
with	O
HIV	other-disease
by	O
the	O
year	O
2007	O
.	O

At	O
least	O
five	O
variants	O
in	O
the	O
SDHD	other-biologything
gene	O
have	O
been	O
identified	O
in	O
people	O
with	O
Cowden	other-disease
syndrome	other-disease
or	O
a	O
similar	O
disorder	O
called	O
Cowden-like	other-disease
syndrome	other-disease
.	O

They	O
work	O
independently	O
of	O
insulin	other-chemicalthing
and	O
can	O
reduce	O
glucose	O
levels	O
without	O
causing	O
hypoglycemia	other-disease
or	O
weight	O
gain	O
.	O

People	O
with	O
G6PD	other-chemicalthing
deficiency	O
are	O
therefore	O
at	O
risk	O
of	O
hemolytic	other-disease
anemia	other-disease
in	O
states	O
of	O
oxidative	O
stress	O
.	O

Presence	O
of	O
tissue	O
bubbles	O
during	O
autopsy	O
is	O
not	O
necessarily	O
an	O
indication	O
of	O
DCS	other-disease
as	O
gas	O
will	O
come	O
out	O
of	O
solution	O
when	O
a	O
body	O
is	O
decompressed	O
by	O
recovering	O
to	O
the	O
surface	O
.	O

He	O
started	O
``	O
The	organization-other
Wedge	organization-other
``	O
,	O
a	O
``	O
safe	O
sex	O
''	O
AIDS	other-disease
prevention	O
organization	O
for	O
teens	O
in	O
San	location-GPE
Francisco	location-GPE
.	O

Without	O
treatment	O
,	O
individuals	O
with	O
impetigo	other-disease
typically	O
get	O
better	O
within	O
three	O
weeks	O
.	O

It	O
contains	O
inactivated	O
purified	O
surface	O
fragments	O
(	O
subunits	O
)	O
from	O
the	O
three	O
different	O
strains	O
of	O
the	O
influenza	O
virus	O
(	O
A/H1N1	other-disease
,	O
A/H3N2	other-disease
,	O
and	O
Influenza	other-disease
B	other-disease
virus	other-disease
)	O
that	O
are	O
selected	O
and	O
distributed	O
by	O
the	O
World	organization-other
Health	organization-other
Organization	organization-other
,	O
on	O
the	O
basis	O
of	O
their	O
latest	O
recommendations	O
.	O

Described	O
as	O
an	O
``	O
instantly	O
recognizable	O
sad-faced	O
actor	O
''	O
,	O
Schiavelli	person-actor
was	O
diagnosed	O
with	O
Marfan	other-disease
syndrome	other-disease
in	O
childhood	O
.	O

NIHL	other-disease
can	O
affect	O
either	O
one	O
or	O
both	O
ears	O
.	O

A	O
visual	O
examination	O
of	O
Chopin	person-artist,author
's	O
preserved	O
heart	O
(	O
the	O
jar	O
was	O
not	O
opened	O
)	O
,	O
conducted	O
in	O
2014	O
and	O
first	O
published	O
in	O
the	O
American	organization-media,newspaper
Journal	organization-media,newspaper
of	organization-media,newspaper
Medicine	organization-media,newspaper
in	O
2017	O
,	O
suggested	O
that	O
the	O
likely	O
cause	O
of	O
his	O
death	O
was	O
a	O
rare	O
case	O
of	O
pericarditis	other-disease
caused	O
by	O
complications	O
of	O
chronic	other-disease
tuberculosis	other-disease
.	O

Byers	person-artist,author
'	O
debut	O
novel	O
``	O
Idiopathy	art-writtenart
``	O
,	O
a	O
satire	O
based	O
on	O
the	O
spread	O
of	O
a	O
BSE	other-disease
-like	O
disease	O
,	O
received	O
a	O
Betty	other-award
Trask	other-award
Award	other-award
and	O
the	O
Waterstones	other-award
11	other-award
prize	O
.	O

HFpEF	other-disease
occurs	O
when	O
the	O
left	O
ventricle	O
contracts	O
normally	O
during	O
systole	O
,	O
but	O
the	O
ventricle	O
is	O
stiff	O
and	O
does	O
not	O
relax	O
normally	O
during	O
diastole	O
,	O
which	O
impairs	O
filling	O
.	O

Those	O
with	O
pre-eclampsia	other-disease
may	O
have	O
a	O
lower	O
risk	O
of	O
breast	O
cancer	O
.	O

Recombinant	O
erythropoietin	O
(	O
EPO	other-biologything
)	O
is	O
very	O
effective	O
in	O
treating	O
the	O
diminished	O
red	other-biologything
blood	other-biologything
cell	other-biologything
production	O
that	O
accompanies	O
end-stage	other-disease
kidney	other-disease
disease	other-disease
.	O

Omalizumab	product-other
inhibits	O
human	O
immunoglobulin	product-other
E	product-other
(	O
IgE	other-biologything
)	O
and	O
is	O
useful	O
in	O
treating	O
moderate-to-severe	O
allergic	other-disease
asthma	other-disease
.	O

Blood	O
tests	O
are	O
also	O
used	O
to	O
identify	O
and	O
measure	O
tumor	other-disease
markers	O
(	O
usually	O
proteins	O
present	O
in	O
the	O
bloodstream	O
)	O
that	O
are	O
specific	O
to	O
testicular	O
cancer	other-disease
.	O

When	O
the	O
depression	other-disease
is	O
caused	O
by	O
a	O
medication	O
,	O
drug	O
of	O
abuse	O
,	O
or	O
exposure	O
to	O
a	O
toxin	O
,	O
it	O
is	O
then	O
diagnosed	O
as	O
a	O
specific	other-disease
mood	other-disease
disorder	other-disease
(	O
previously	O
called	O
``	O
substance-induced	other-disease
mood	other-disease
disorder	other-disease
``	O
in	O
the	O
DSM-IV-TR	art-writtenart
)	O
.	O

The	O
United	organization-other
States	organization-other
Preventive	organization-other
Services	organization-other
Task	organization-other
Force	organization-other
(	O
USPSTF	organization-other
)	O
recommends	O
screening	O
for	O
gonorrhea	other-disease
in	O
women	O
at	O
increased	O
risk	O
of	O
infection	O
,	O
which	O
includes	O
all	O
sexually	O
active	O
women	O
younger	O
than	O
25	O
years	O
.	O

Anterior	O
pituitary	O
function	O
must	O
be	O
normal	O
for	O
all	O
other	O
axes	O
in	O
CHH	other-disease
as	O
it	O
is	O
an	O
isolated	O
disorder	O
.	O

The	O
BBC	organization-media,newspaper
later	O
reversed	O
the	O
decision	O
,	O
claiming	O
the	O
original	O
move	O
was	O
due	O
to	O
the	O
Coronavirus	other-disease
social-distancing	O
measures	O
,	O
and	O
that	O
they	O
would	O
now	O
be	O
sung	O
.	O

A	O
level	O
of	O
50	O
%	O
carboxyhemoglobin	other-chemicalthing
may	O
result	O
in	O
seizure	other-disease
,	O
coma	other-disease
,	O
and	O
fatality	other-disease
.	O

The	O
search	O
for	O
a	O
lazaret	O
site	O
in	O
northern	location-GPE
Queensland	location-GPE
followed	O
a	O
succession	O
of	O
other	O
attempts	O
to	O
segregate	O
Hansen	other-disease
's	other-disease
disease	other-disease
patients	O
.	O

The	O
observation	O
that	O
DFNA5	other-biologything
is	O
epigenetically	O
inactivated	O
in	O
a	O
large	O
number	O
of	O
cancers	O
of	O
frequent	O
types	O
(	O
gastric	other-disease
,	O
colorectal	other-disease
,	O
and	O
breast	other-disease
)	O
is	O
another	O
important	O
finding	O
and	O
is	O
in	O
line	O
with	O
its	O
apoptosis-inducing	O
properties	O
.	O

However	O
subsequent	O
reports	O
asserted	O
that	O
Google	organization-company
Flu	other-disease
Trends	O
'	O
predictions	O
have	O
sometimes	O
been	O
very	O
inaccurate—especially	O
over	O
the	O
interval	O
2011–2013	O
,	O
when	O
it	O
consistently	O
overestimated	O
relative	O
flu	O
incidence	O
,	O
and	O
over	O
one	O
interval	O
in	O
the	O
2012-2013	O
flu	O
season	O
predicted	O
twice	O
as	O
many	O
doctors	O
'	O
visits	O
as	O
the	O
CDC	organization-government,governmentagency
recorded	O
.	O

Individuals	O
with	O
Pitt–Hopkins	other-disease
syndrome	other-disease
typically	O
have	O
a	O
happy	O
,	O
excitable	O
demeanor	O
with	O
frequent	O
smiling	O
and	O
laughter	O
.	O

Migraine	other-disease
surgery	O
is	O
usually	O
reserved	O
for	O
migraine	other-disease
patients	O
who	O
fail	O
more	O
conservative	O
therapy	O
or	O
who	O
can	O
not	O
tolerate	O
the	O
side	O
effects	O
of	O
drugs	O
used	O
to	O
treat	O
their	O
migraines	other-disease
.	O

Microscopically	O
there	O
are	O
epithelioid	other-disease
granulomas	other-disease
and	O
vasculitis	other-disease
in	O
the	O
subcutaneous	O
tissue	O
,	O
making	O
it	O
a	O
form	O
of	O
paniculitis	other-disease
.	O

Fungi	O
responsible	O
for	O
fungal	O
sinusitis	O
are	O
``	O
Aspergillus	other-disease
fumigatus	other-disease
``	O
(	O
90	O
%	O
)	O
,	O
``	O
Aspergillus	other-disease
flavus	other-disease
``	O
,	O
and	O
``	O
Aspergillus	other-disease
niger	other-disease
``	O
.	O

Depression	other-disease
can	O
be	O
treated	O
with	O
s	O
elective	other-chemicalthing
serotonin	other-chemicalthing
reuptake	other-chemicalthing
inhibitors	other-chemicalthing
(	O
SSRIs	other-chemicalthing
)	O
or	O
tricyclic	other-chemicalthing
antidepressants	other-chemicalthing
,	O
while	O
benzodiazepines	other-chemicalthing
can	O
be	O
used	O
for	O
anxiety	other-disease
.	O

Rheumatic	other-disease
fever	other-disease
is	O
common	O
worldwide	O
and	O
responsible	O
for	O
many	O
cases	O
of	O
damaged	O
heart	O
valves	O
.	O

In	O
the	O
United	location-GPE
States	location-GPE
,	O
chlorination	O
of	O
the	O
water	O
kills	O
Hepatitis	other-disease
A	other-disease
virus	O
that	O
enters	O
the	O
water	O
supply	O
.	O

Sexual	other-disease
dysfunction	other-disease
is	O
particularly	O
common	O
among	O
people	O
affected	O
by	O
panic	other-disease
disorder	other-disease
(	O
who	O
may	O
fear	O
that	O
a	O
panic	O
attack	O
will	O
occur	O
during	O
sexual	O
arousal	O
)	O
and	O
posttraumatic	other-disease
stress	other-disease
disorder	other-disease
.	O

Shortly	O
before	O
his	O
death	O
,	O
he	O
tested	O
positive	O
for	O
COVID-19	other-disease
,	O
which	O
was	O
later	O
listed	O
as	O
the	O
cause	O
of	O
death	O
.	O

Breast	other-disease
cancer	other-disease
was	O
also	O
listed	O
as	O
a	O
significant	O
condition	O
on	O
her	O
death	O
certificate	O
.	O

Pneumothorax	O
is	O
a	O
well-known	O
complication	O
of	O
PCP	other-disease
.	O

Rarely	O
(	O
&	O
lt	O
;	O
5	O
%	O
)	O
children	O
with	O
BWS	other-disease
will	O
continue	O
to	O
have	O
hypoglycemia	other-disease
after	O
the	O
neonatal	O
period	O
and	O
require	O
more	O
intensive	O
treatment	O
.	O

In	O
2011	O
,	O
Pampers	organization-company
joined	O
with	O
UNICEF	organization-other
to	O
target	O
maternal	O
and	O
neonatal	other-disease
tetanus	other-disease
in	O
Yemen	location-GPE
.	O

Professor	O
Akiskal	person-other
rose	O
to	O
prominence	O
with	O
his	O
integrative	O
theory	O
of	O
depression	other-disease
.	O

The	O
molecule	O
is	O
highly	O
expressed	O
in	O
a	O
variety	O
of	O
cancer	O
cell	O
types	O
,	O
most	O
notably	O
breast	other-disease
cancer	other-disease
.	O

In	O
1991	O
,	O
the	O
World	organization-other
Health	organization-other
Assembly	organization-other
agreed	O
that	O
Guinea	other-disease
worm	O
disease	O
should	O
be	O
eradicated	O
.	O

The	O
potassium	other-disease
deficiency	other-disease
may	O
also	O
be	O
a	O
result	O
of	O
the	O
Chinese	location-GPE
diet	O
or	O
genetic	O
predisposition	O
.	O

Hepatorenal	other-disease
syndrome	other-disease
is	O
one	O
of	O
the	O
more	O
serious	O
complications	O
in	O
patients	O
with	O
an	O
acute	other-disease
decompensation	other-disease
of	other-disease
cirrhosis	other-disease
and	O
increased	O
portal	other-disease
hypertension	other-disease
.	O

Study	O
has	O
collected	O
wide-ranging	O
data	O
and	O
has	O
focused	O
on	O
risk	O
factors	O
that	O
predict	O
vascular	other-disease
disease	other-disease
,	O
diabetes	other-disease
,	O
cognitive	other-disease
impairmen	other-disease
t	O
and	O
dementia	other-disease
—	O
and	O
the	O
benefits	O
of	O
living	O
a	O
healthy	O
lifestyle	O
.	O

Some	O
other	O
neurodegenerative	O
diseases	O
including	O
Alzheimer	other-disease
's	other-disease
disease	other-disease
(	O
AD	other-disease
)	O
,	O
dementia	other-disease
with	other-disease
Lewy	other-disease
bodies	other-disease
(	O
DLB	other-disease
)	O
,	O
chronic	other-disease
traumatic	other-disease
encephalopathy	other-disease
(	O
CTE	other-disease
)	O
and	O
frontotemporal	other-disease
dementia	other-disease
(	O
FTD	other-disease
)	O
also	O
show	O
commonalities	O
with	O
CBD	other-disease
.	O

Congestive	other-disease
heart	other-disease
failure	other-disease
and	O
cardiac	other-disease
arrhythmia	other-disease
are	O
the	O
leading	O
causes	O
of	O
death	O
,	O
but	O
patients	O
with	O
less	O
severe	O
symptoms	O
can	O
live	O
into	O
their	O
60s	O
or	O
older	O
.	O

Paraplegia	other-disease
is	O
an	O
impairment	O
in	O
motor	O
or	O
sensory	O
function	O
of	O
the	O
lower	O
extremities	O
.	O

These	O
interactions	O
would	O
be	O
expected	O
to	O
be	O
most	O
significant	O
with	O
long-term	O
diazepam	other-disease
therapy	O
,	O
and	O
their	O
clinical	O
significance	O
is	O
variable	O
.	O

For	O
example	O
,	O
one	O
group	O
found	O
a	O
positive	O
correlation	O
between	O
persistently	O
activated	O
tyrosine-phosphorylated	other-biologything
STAT3	other-biologything
(	O
pSTAT3	other-biologything
)	O
,	O
found	O
in	O
50	O
%	O
of	O
lung	other-disease
adenocarcinomas	other-disease
,	O
and	O
IL-6	other-biologything
.	O

This	O
explains	O
why	O
ferritin	other-biologything
levels	O
remain	O
relative	O
low	O
in	O
Hereditary	other-disease
hemochromatosis	other-disease
,	O
while	O
transferrin	other-biologything
saturation	O
is	O
high	O
.	O

Folic	other-disease
acid	other-disease
deficiency	other-disease
is	O
a	O
common	O
association	O
of	O
nutritional	other-disease
anemia	other-disease
and	O
iron	other-disease
deficiency	other-disease
anemia	other-disease
is	O
the	O
most	O
common	O
nutritional	O
disorder	O
.	O

If	O
a	O
patient	O
does	O
not	O
exhibit	O
mitochondrial	O
DNA	O
mutations	O
,	O
there	O
are	O
other	O
ways	O
that	O
they	O
can	O
be	O
diagnosed	O
with	O
MERRF	other-disease
.	O

Thyroid-stimulating	other-biologything
hormone	other-biologything
(	O
TSH	other-biologything
)	O
deficiency	O
leads	O
to	O
hypothyroidism	O
(	O
lack	O
of	O
production	O
of	O
thyroxine	O
(	O
T4	other-disease
)	O
and	O
triiodothyronine	O
(	O
T3	other-disease
)	O
in	O
the	O
thyroid	O
)	O
.	O

The	O
players	O
have	O
disabilities	O
such	O
as	O
Cerebral	other-disease
Palsy	other-disease
,	O
Duchenne	other-disease
muscular	other-disease
dystrophy	other-disease
,	O
Spina	other-disease
Bifida	other-disease
and	O
Hydrocephalus	other-disease
.	O

Increased	O
nuclear	O
β-catenin	other-biologything
levels	O
have	O
also	O
been	O
noted	O
in	O
basal	other-disease
cell	other-disease
carcinoma	other-disease
(	O
BCC	other-disease
)	O
,	O
head	other-disease
and	other-disease
neck	other-disease
squamous	other-disease
cell	other-disease
carcinoma	other-disease
(	O
HNSCC	other-disease
)	O
,	O
prostate	other-disease
cancer	other-disease
(	O
CaP	other-disease
)	O
,	O
pilomatrixoma	other-disease
(	O
PTR	other-disease
)	O
and	O
medulloblastoma	other-disease
(	O
MDB	other-disease
)	O
These	O
observations	O
may	O
or	O
may	O
not	O
implicate	O
a	O
mutation	O
in	O
the	O
β-catenin	other-biologything
gene	O
:	O
other	O
Wnt	other-biologything
pathway	other-biologything
components	O
can	O
also	O
be	O
faulty	O
.	O

These	O
masculine	O
characteristics	O
include	O
:	O
clitoral	other-disease
hypertrophy	other-disease
,	O
androgenic	other-disease
alopecia	other-disease
,	O
growth	O
of	O
body	O
hair	O
and	O
deepening	O
of	O
the	O
vocal	O
cords	O
.	O

Holtzman	person-scholar
's	O
lab	O
is	O
known	O
for	O
uncovering	O
how	O
apoE4	other-biologything
contributes	O
to	O
Alzheimer	other-disease
's	O
disease	O
as	O
well	O
as	O
how	O
synaptic	O
activity	O
and	O
sleep	O
modulate	O
amyloid	other-biologything
beta	other-biologything
and	O
tau	other-biologything
levels	O
in	O
the	O
brain	O
.	O

Research	O
proposes	O
patients	O
with	O
bipolar	other-disease
disorder	other-disease
show	O
more	O
common	O
implicit	O
and	O
depressive	O
self-referencing	O
than	O
unipolar	O
patients	O
.	O

A	O
person	O
with	O
spatial	other-disease
dysgraphia	other-disease
has	O
a	O
defect	O
in	O
the	O
understanding	O
of	O
space	O
.	O

A	O
third	O
type	O
of	O
pituitary	other-disease
adenoma	other-disease
secretes	O
excess	O
ACTH	other-biologything
,	O
which	O
in	O
turn	O
,	O
causes	O
an	O
excess	O
of	O
cortisol	O
to	O
be	O
secreted	O
and	O
is	O
the	O
cause	O
of	O
Cushing	other-disease
's	O
disease	O
.	O

Using	O
his	O
theory	O
and	O
reading	O
John	person-scholar
Snow	person-scholar
's	O
essay	O
about	O
cholera	other-disease
in	O
London	location-GPE
(	O
1849	O
)	O
,	O
Budd	person-scholar
took	O
measures	O
to	O
protect	O
the	O
Bristol	location-GPE
's	O
water	O
supply	O
.	O

The	O
most	O
common	O
cause	O
of	O
expressive	other-disease
aphasia	other-disease
is	O
stroke	other-disease
.	O

Dwarfism	other-disease
can	O
result	O
from	O
many	O
medical	O
conditions	O
,	O
each	O
with	O
its	O
own	O
separate	O
symptoms	O
and	O
causes	O
.	O

It	O
can	O
also	O
cause	O
a	O
type	O
of	O
septicaemia	other-disease
called	O
pyaemia	other-disease
.	O

Complications	O
may	O
include	O
cellulitis	other-disease
or	O
poststreptococcal	other-disease
glomerulonephritis	other-disease
.	O

However	O
,	O
these	O
physical	O
examination	O
findings	O
are	O
also	O
present	O
in	O
Valentino	other-disease
’	other-disease
s	other-disease
Syndrome	other-disease
.	O

Autoimmune	other-disease
variants	other-disease
peripheral	other-disease
neuropathies	other-disease
or	O
progressive	other-disease
inflammatory	other-disease
neuropathy	other-disease
could	O
be	O
in	O
the	O
list	O
assuming	O
the	O
autoimmune	O
model	O
for	O
MS	other-disease
,	O
together	O
with	O
a	O
rare	O
demyelinating	other-disease
lesional	other-disease
variant	other-disease
of	other-disease
trigeminal	other-disease
neuralgia	other-disease
and	O
some	O
NMDAR	O
Anti-NMDA	O
receptor	O
encephalitis	O

A	O
patient	O
with	O
GSD	other-disease
,	O
type	O
1b	O
was	O
treated	O
with	O
a	O
liver	O
transplant	O
at	O
UCSF	organization-other
Medical	organization-other
Center	organization-other
in	O
1993	O
that	O
resulted	O
in	O
the	O
resolution	O
of	O
hypoglycemic	O
episodes	O
and	O
the	O
need	O
for	O
the	O
patient	O
to	O
stay	O
away	O
from	O
natural	O
sources	O
of	O
sugar	O
.	O

Genetic	O
counseling	O
is	O
usually	O
offered	O
to	O
women	O
at	O
a	O
higher	O
risk	O
of	O
having	O
a	O
child	O
with	O
a	O
neural	O
tube	O
defect	O
to	O
discuss	O
available	O
testing.It	O
is	O
known	O
that	O
people	O
taking	O
certain	O
anticonvulsants	O
and	O
people	O
with	O
insulin-dependent	O
diabetes	O
have	O
a	O
higher	O
risk	O
of	O
having	O
a	O
child	O
with	O
a	O
neural	other-disease
tube	other-disease
defect	other-disease
.	O

Purpura	other-disease
fulminans	other-disease
secondary	O
to	O
severe	O
infection	O
is	O
self-limiting	O
.	O

She	O
continued	O
to	O
study	O
the	O
vascular	O
biology	O
of	O
HIV	other-disease
infection	O
and	O
the	O
effects	O
of	O
HIV	other-disease
infection	O
on	O
the	O
central	O
nervous	O
system	O
.	O

It	O
was	O
announced	O
in	O
January	O
2009	O
that	O
a	O
character	O
with	O
Asperger	other-disease
syndrome	other-disease
would	O
be	O
arriving	O
in	O
March	O
and	O
would	O
``	O
immediately	O
cause	O
some	O
consternation	O
amongst	O
her	O
fellow	O
colleagues	O
.	O
''	O

The	O
first	O
appearance	O
of	O
mono-ADP-ribosylation	other-biologything
occurred	O
a	O
year	O
later	O
during	O
a	O
study	O
of	O
toxins	O
:	O
corynebacterium	other-disease
diphtheria	other-disease
diphtheria	other-disease
toxin	other-disease
was	O
shown	O
to	O
be	O
dependent	O
on	O
NAD+	other-biologything
in	O
order	O
for	O
it	O
to	O
be	O
completely	O
effective	O
,	O
leading	O
to	O
the	O
discovery	O
of	O
enzymatic	other-biologything
conjugation	other-biologything
of	other-biologything
a	other-biologything
single	other-biologything
ADP-ribose	other-biologything
group	other-biologything
by	O
mono-ADP-ribosyl	other-biologything
transferase	other-biologything
.	O

Fearing	O
worse	O
,	O
Martin	person-other
's	O
testing	O
efforts	O
ruled	O
out	O
contagious	O
diseases	O
,	O
like	O
Lassa	other-disease
fever	other-disease
or	O
ebola	other-disease
which	O
have	O
much-higher	O
mortality	O
rates	O
.	O

CES-I	other-disease
with	O
its	O
more	O
favourable	O
prognosis	O
may	O
become	O
CES-R	other-disease
at	O
a	O
later	O
stage	O
.	O

The	O
Swine	other-disease
Flu	other-disease
(	O
also	O
known	O
as	O
H1N1	other-disease
)	O
epidemic	O
is	O
a	O
recent	O
disease	O
emerging	O
in	O
the	O
early	O
21st	O
century	O
.	O

Hayden	person-other
's	O
research	O
focus	O
is	O
primarily	O
on	O
genetic	O
diseases	O
,	O
including	O
genetics	other-disease
of	other-disease
[	other-disease
lipoprotein	other-disease
]	other-disease
disorders	other-disease
,	O
Huntington	other-disease
disease	other-disease
,	O
predictive	O
medicine	O
,	O
personalized	O
medicine	O
and	O
drug	O
development	O
.	O

DSM-5	art-writtenart
states	O
that	O
if	O
a	O
patient	O
only	O
experiences	O
psychotic	O
symptoms	O
during	O
a	O
mood	O
episode	O
,	O
their	O
diagnosis	O
is	O
Mood	other-disease
Disorder	other-disease
with	O
Psychotic	other-disease
Features	other-disease
and	O
not	O
Schizophrenia	other-disease
or	O
Schizoaffective	other-disease
Disorder	other-disease
.	O

It	O
is	O
also	O
being	O
studied	O
in	O
the	O
treatment	O
of	O
other	O
types	O
of	O
cancer	O
,	O
such	O
as	O
lung	other-disease
cancer	other-disease
.	O

Gastroesophageal	other-disease
reflux	other-disease
disease	O
is	O
the	O
most	O
common	O
cause	O
of	O
heartburn	O
.	O

Risk	O
factors	O
for	O
acute	O
cases	O
include	O
swimming	O
,	O
minor	O
trauma	O
from	O
cleaning	O
,	O
using	O
hearing	O
aids	O
and	O
ear	O
plugs	O
,	O
and	O
other	O
skin	O
problems	O
,	O
such	O
as	O
psoriasis	other-disease
and	O
dermatitis	other-disease
.	O

People	O
with	O
the	O
so-called	O
segmental	O
progerias	other-disease
are	O
vulnerable	O
to	O
different	O
sets	O
of	O
diseases	O
.	O

Patients	O
with	O
blepharospasm	other-disease
have	O
normal	O
eyes	O
.	O

Teva	person-other
and	O
Technion	person-other
filed	O
patent	O
applications	O
for	O
this	O
racemically	O
pure	O
compound	O
,	O
methods	O
to	O
make	O
it	O
,	O
and	O
methods	O
to	O
use	O
it	O
to	O
treat	O
Parkinsons	other-disease
and	O
other	O
disorders	O
,	O
and	O
Technion	person-other
eventually	O
assigned	O
its	O
rights	O
to	O
Teva	person-other
.	O

Urinary	other-disease
incontinence	other-disease
and	O
gait	other-disease
apraxia	other-disease
are	O
also	O
not	O
uncommon	O
findings	O
.	O

On	O
July	O
2nd	O
2020	O
,	O
Dickinson	person-other
died	O
at	O
his	O
Highgate	location-GPE
home	O
of	O
peritonitis	other-disease
resulting	O
from	O
a	O
gut	other-disease
obstruction	other-disease
.	O

It	O
is	O
associated	O
with	O
diabetes	other-disease
and	O
long-term	O
tobacco	O
smoking	O
.	O

If	O
rheumatoid	other-disease
arthritis	other-disease
is	O
present	O
and	O
other	O
symptoms	O
occur	O
that	O
are	O
not	O
commonly	O
found	O
within	O
RA	O
itself	O
,	O
such	O
as	O
a	O
palpable	O
spleen	O
,	O
further	O
testing	O
should	O
be	O
done	O
.	O

Other	O
names	O
for	O
dry	O
eye	O
include	O
dry	O
eye	O
syndrome	O
,	O
keratoconjunctivitis	other-disease
sicca	other-disease
(	O
KCS	other-disease
)	O
,	O
dysfunctional	other-disease
tear	other-disease
syndrome	other-disease
,	O
lacrimal	other-disease
keratoconjunctivitis	other-disease
,	O
evaporative	other-disease
tear	other-disease
deficiency	other-disease
,	O
aqueous	other-disease
tear	other-disease
deficiency	other-disease
,	O
and	O
LASIK-induced	other-disease
neurotrophic	other-disease
epitheliopathy	other-disease
(	O
LNE	other-disease
)	O
.	O

WEA	other-disease
is	O
present	O
in	O
about	O
a	O
fifth	O
of	O
patients	O
with	O
asthma	other-disease
and	O
a	O
wide	O
variety	O
of	O
conditions	O
at	O
work	O
,	O
including	O
irritant	O
chemicals	O
,	O
dusts	O
,	O
second-hand	O
smoke	O
,	O
common	O
allergens	O
that	O
may	O
be	O
present	O
at	O
work	O
,	O
as	O
well	O
as	O
other	O
“	O
exposures	O
”	O
such	O
as	O
emotional	O
stress	O
,	O
worksite	O
temperature	O
,	O
and	O
physical	O
exertion	O
can	O
exacerbate	O
asthma	other-disease
symptoms	O
in	O
these	O
patients	O
.	O

For	O
a	O
diagnosis	O
of	O
sleep	other-disease
apnea	other-disease
,	O
more	O
than	O
five	O
episodes	O
per	O
hour	O
must	O
occur	O
.	O

Autoimmune	O
conditions	O
related	O
to	O
gluten	other-disease
include	O
celiac	other-disease
disease	other-disease
,	O
dermatitis	other-disease
herpetiformis	other-disease
,	O
and	O
gluten	other-disease
ataxia	other-disease
.	O

Clomifene	other-biologything
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
malignant	O
melanomas	O
and	O
thyroid	other-disease
cancer	other-disease
.	O

Aseptic	O
meningitis	O
is	O
caused	O
by	O
viruses	other-disease
,	O
mycobacteria	other-disease
,	O
spirochetes	other-disease
,	O
fungi	O
,	O
medications	O
,	O
and	O
cancer	other-disease
malignancies	other-disease
.	O

In	O
2000	O
,	O
the	O
World	organization-other
Health	organization-other
Organization	organization-other
(	O
WHO	organization-other
)	O
listed	O
91	O
countries	O
in	O
which	O
Hansen	other-disease
's	other-disease
disease	other-disease
is	O
endemic	O
.	O

The	O
use	O
of	O
computed	O
tomography	O
scan	O
for	O
the	O
diagnosis	O
of	O
Wilms	other-disease
'	other-disease
tumor	other-disease
began	O
in	O
early	O
1970s	O
,	O
thanks	O
to	O
the	O
intuition	O
of	O
Dr.	person-other
Mario	person-other
Costici	person-other
,	O
an	O
Italian	location-GPE
physician	O
.	O

Surveillance	O
for	O
cholangiocarcinoma	O
in	O
patients	O
with	O
PSC	other-disease
is	O
encouraged	O
,	O
with	O
some	O
experts	O
recommending	O
annual	O
surveillance	O
with	O
a	O
specialized	O
imaging	O
study	O
and	O
serum	O
markers	O
,	O
although	O
consensus	O
regarding	O
the	O
modality	O
and	O
interval	O
has	O
yet	O
to	O
be	O
established	O
.	O

is	O
a	O
subtype	O
of	O
anosognosia	other-disease
in	O
which	O
the	O
person	O
suffering	O
from	O
hemiplegia	other-disease
neglects	O
one	O
half	O
of	O
their	O
body	O
.	O

In	O
1987	O
,	O
Shay	person-scholar
shifted	O
from	O
neuropathology	O
to	O
the	O
study	O
of	O
posttraumatic	other-disease
stress	other-disease
disorder	other-disease
(	O
PTSD	other-disease
)	O
and	O
published	O
a	O
short	O
article	O
linking	O
the	O
combat	O
histories	O
of	O
patients	O
at	O
the	O
VA	O
with	O
the	O
experience	O
of	O
war	O
described	O
in	O
Homer	person-scholar
's	O
``	O
Iliad	art-writtenart
``	O
.	O

It	O
was	O
notable	O
for	O
featuring	O
the	O
first	O
use	O
of	O
fireworks	O
at	O
the	O
site	O
since	O
2008	O
and	O
for	O
being	O
held	O
amid	O
the	O
ongoing	O
COVID-19	other-disease
pandemic	O
.	O

In	O
1981	O
Schwartz	person-other
led	O
one	O
of	O
the	O
three	O
groups	O
that	O
first	O
described	O
AIDS-associated	other-disease
Kaposi	other-disease
sarcoma	other-disease
(	O
KS-AIDS	other-disease
)	O
.	O

Copper	other-chemicalthing
and	O
zinc	other-chemicalthing
are	O
known	O
to	O
bind	O
to	O
amyloid	other-biologything
beta	other-biologything
proteins	other-biologything
in	O
Alzheimer	other-disease
's	other-disease
disease	other-disease
.	O

In	O
2008	O
,	O
the	O
World	organization-other
Health	organization-other
Organization	organization-other
defined	O
a	O
specific	O
type	O
of	O
lymphoma	other-disease
,	O
enteropathy-associated	other-disease
T	other-disease
cell	other-disease
lymphoma	other-disease
(	O
EATL	other-disease
)	O
,	O
as	O
having	O
two	O
different	O
types	O
:	O
EATL	other-disease
type	other-disease
I	other-disease
,	O
a	O
lymphoma	other-disease
occurring	O
in	O
patients	O
with	O
the	O
chronic	O
,	O
autoimmune	O
GI	other-disease
tract	other-disease
disorder	other-disease
,	O
celiac	other-disease
disease	other-disease
,	O
and	O
EATL	other-disease
type	other-disease
II	other-disease
,	O
a	O
similar	O
bowel	O
lymphoma	O
that	O
was	O
not	O
associated	O
with	O
celiac	O
disease	O
.	O

In	O
2002	O
,	O
763,917	O
new	O
cases	O
were	O
detected	O
worldwide	O
,	O
and	O
in	O
that	O
year	O
the	O
WHO	organization-other
listed	O
India	location-GPE
,	O
Brazil	location-GPE
,	O
Madagascar	location-GPE
,	O
Mozambique	location-GPE
,	O
Tanzania	location-GPE
and	O
Nepal	location-GPE
as	O
having	O
90	O
%	O
of	O
Hansen	other-disease
's	other-disease
disease	other-disease
cases	O
.	O

Butternut	O
squash	O
seeds	O
have	O
been	O
cited	O
for	O
reducing	O
social	other-disease
anxiety	other-disease
disorder	other-disease
within	O
an	O
hour	O
of	O
consumption	O
in	O
a	O
double-blind	O
trial	O
.	O

As	O
a	O
result	O
,	O
the	O
cells	O
are	O
inflexible	O
and	O
can	O
not	O
easily	O
flow	O
through	O
blood	O
vessels	O
,	O
increasing	O
the	O
risk	O
of	O
blood	other-disease
clots	other-disease
and	O
possibly	O
depriving	O
vital	O
organs	O
of	O
oxygen	O
.	O

Brain	other-disease
ischemia	other-disease
is	O
insufficient	O
blood	O
flow	O
to	O
the	O
brain	O
,	O
and	O
can	O
be	O
acute	O
or	O
chronic	O
.	O

In	O
this	O
case	O
,	O
the	O
delusion	other-disease
does	O
not	O
cease	O
to	O
be	O
a	O
delusion	other-disease
because	O
the	O
content	O
later	O
turns	O
out	O
to	O
be	O
verified	O
as	O
true	O
or	O
the	O
partner	O
actually	O
chose	O
to	O
engage	O
in	O
the	O
behavior	O
of	O
which	O
they	O
were	O
being	O
accused	O
.	O

Within	O
the	O
ICD-10	O
category	O
scheme	O
,	O
disinhibited	other-disease
attachment	other-disease
disorder	other-disease
specifically	O
excludes	O
Asperger	other-disease
syndrome	other-disease
(	O
F84.5	O
)	O
,	O
hospitalism	other-disease
in	other-disease
children	other-disease
(	O
F43.2	O
)	O
,	O
and	O
hyperkinetic	other-disease
disorders	other-disease
(	O
F90.-	O
)	O
.	O

Also	O
applicable	O
is	O
the	O
Virchow	other-disease
's	other-disease
triad	other-disease
of	other-disease
blood	other-disease
stasis	other-disease
,	O
endothelial	other-disease
injury	other-disease
,	O
and	O
hypercoagulable	other-disease
state	other-disease
.	O

The	O
condition	O
was	O
formerly	O
called	O
Huntington	other-disease
's	other-disease
chorea	other-disease
but	O
was	O
renamed	O
because	O
of	O
the	O
important	O
non-choreic	O
features	O
including	O
cognitive	O
decline	O
and	O
behavioural	O
change	O
.	O

Morquio	other-disease
syndrome	other-disease
,	O
also	O
known	O
as	O
Mucopolysaccharidosis	other-disease
Type	other-disease
IV	other-disease
(	O
MPS	other-disease
IV	other-disease
)	O
,	O
is	O
a	O
rare	O
metabolic	O
disorder	O
in	O
which	O
the	O
body	O
can	O
not	O
process	O
certain	O
types	O
of	O
sugar	O
molecules	O
called	O
glycosaminoglycans	other-biologything
(	O
AKA	other-biologything
GAGs	other-biologything
,	O
or	O
mucopolysaccharides	other-biologything
)	O
.	O

Conduct	other-disease
disorder	other-disease
is	O
associated	O
with	O
both	O
structural	O
abnormalities	O
,	O
and	O
functional	O
abnormalities	O
during	O
affective	O
tasks	O
.	O

The	O
hematoma	other-disease
usually	O
extends	O
into	O
the	O
nasal	O
passage	O
.	O

When	O
12-week-old	O
Bernard	person-other
Myers	person-other
died	O
in	O
the	O
hospital	O
after	O
being	O
caught	O
in	O
the	O
tear	O
gas	O
attack	O
,	O
a	O
government	O
investigation	O
reported	O
he	O
died	O
of	O
enteritis	other-disease
,	O
and	O
a	O
hospital	O
spokesman	O
said	O
the	O
tear	O
gas	O
``	O
did	O
n't	O
do	O
it	O
any	O
good	O
.	O
''	O

The	O
FDA	organization-government,governmentagency
says	O
that	O
it	O
has	O
known	O
for	O
some	O
time	O
that	O
the	O
morcellators	O
could	O
spread	O
uterine	other-disease
cancer	other-disease
,	O
but	O
the	O
recent	O
attention	O
given	O
to	O
the	O
subject	O
because	O
of	O
the	O
death	O
of	O
Barbara	person-other
Leary	person-other
led	O
them	O
to	O
reopen	O
the	O
investigation	O
,	O
and	O
they	O
discovered	O
a	O
higher	O
risk	O
than	O
was	O
initially	O
reported	O
.	O

The	O
clinical	O
features	O
of	O
TBS	other-disease
overlap	O
with	O
VATER	other-disease
and	O
VACTERL	other-disease
associations	O
,	O
oculo-auriculo-vertebral	other-disease
(	O
OAV	other-disease
)	O
spectrum	O
,	O
branchio-oto-renal	other-disease
(	O
BOR	other-disease
)	O
syndrome	O
,	O
and	O
Fanconi	other-disease
anemia	other-disease
and	O
other	O
'anus-hand-ear	O
'	O
syndromes	O
.	O

Groenewegen	person-athlete
was	O
diagnosed	O
with	O
Type	other-disease
1	other-disease
Diabetes	other-disease
at	O
the	O
age	O
of	O
nine	O
,	O
but	O
did	O
not	O
let	O
this	O
disease	O
control	O
her	O
,	O
persisting	O
to	O
become	O
a	O
member	O
of	O
the	O
Canada	location-GPE
women	O
's	O
national	O
softball	O
team	O
at	O
the	O
age	O
of	O
17	O
.	O

Mutation	O
in	O
the	O
CACNA1C	other-biologything
gene	O
,	O
the	O
single-nucleotide	other-biologything
polymorphism	other-biologything
located	O
in	O
the	O
third	O
intron	O
of	O
the	O
Cav1.2	other-biologything
gene	O
,	O
are	O
associated	O
with	O
a	O
variant	O
of	O
Long	other-disease
QT	other-disease
syndrome	other-disease
called	O
Timothy	other-disease
's	other-disease
syndrome	other-disease
and	O
also	O
with	O
Brugada	O
syndrome	O
.	O

Pericarditis	other-disease
caused	O
by	O
tuberculosis	O
is	O
difficult	O
to	O
diagnose	O
,	O
because	O
definitive	O
diagnosis	O
requires	O
culturing	O
``	O
Mycobacterium	other-biologything
tuberculosis	other-biologything
``	O
from	O
aspirated	O
pericardial	O
fluid	O
or	O
pericardial	O
,	O
which	O
requires	O
high	O
technical	O
skill	O
and	O
is	O
often	O
not	O
diagnostic	O
(	O
the	O
yield	O
from	O
culture	O
is	O
low	O
even	O
with	O
optimum	O
specimens	O
)	O
.	O

The	O
tumor	other-disease
often	O
has	O
a	O
cauliflower-like	O
appearance	O
.	O

Anxiety	other-disease
disorders	other-disease
often	O
co-occur	O
with	O
ASPD	other-disease
,	O
and	O
contrary	O
to	O
assumptions	O
,	O
psychopathy	O
can	O
sometimes	O
be	O
marked	O
by	O
anxiety	O
;	O
this	O
appears	O
to	O
be	O
related	O
to	O
items	O
from	O
Factor	O
2	O
but	O
not	O
Factor	O
1	O
of	O
the	O
PCL-R	O
.	O
Psychopathy	other-disease
is	O
also	O
associated	O
with	O
substance	O
use	O
disorders	O
.	O

Research	O
efforts	O
during	O
the	O
80-90s	O
have	O
shown	O
that	O
myocardial	other-disease
ischemia	other-disease
also	O
induces	O
changes	O
to	O
the	O
depolarization	O
phase	O
and	O
confirmed	O
the	O
use	O
of	O
HFQRS-RMS	O
as	O
a	O
quantitative	O
diagnostic	O
measure	O
of	O
supply	O
myocardial	other-disease
ischemia	other-disease
and	O
demand	O
myocardial	other-disease
(	other-disease
stress-induced	other-disease
)	other-disease
ischemia	other-disease
.	O

This	O
abnormal	O
protein	other-biologything
builds	O
up	O
in	O
the	O
brain	O
and	O
destroys	O
nerve	O
cells	O
,	O
resulting	O
in	O
the	O
signs	O
and	O
symptoms	O
of	O
prion	other-disease
disease	other-disease
.	O

Influenza	other-disease
B	other-disease
and	other-disease
C	other-disease
principally	O
infect	O
humans	O
,	O
minimizing	O
the	O
chance	O
that	O
a	O
reassortment	O
will	O
change	O
its	O
phenotype	O
drastically	O
.	O

Common	O
adverse	O
effects	O
in	O
studies	O
were	O
temporary	other-disease
bradycardia	other-disease
(	O
slow	other-disease
heartbeat	other-disease
)	O
,	O
usually	O
at	O
the	O
beginning	O
of	O
the	O
treatment	O
,	O
dyspnoea	other-disease
(	O
breathing	other-disease
difficulties	other-disease
)	O
,	O
and	O
increased	other-disease
liver	other-disease
enzymes	other-disease
(	O
without	O
symptoms	O
)	O
.	O

Monkeypox	other-disease
as	O
a	O
disease	O
in	O
humans	O
was	O
first	O
associated	O
with	O
an	O
illness	O
in	O
the	O
Democratic	location-GPE
Republic	location-GPE
of	location-GPE
the	location-GPE
Congo	location-GPE
(	O
formerly	O
Zaire	location-GPE
)	O
,	O
in	O
the	O
town	O
of	O
Basankusu	location-GPE
,	O
Équateur	location-GPE
Province	O
,	O
in	O
1970	O
.	O

It	O
may	O
also	O
be	O
used	O
together	O
with	O
fluorouracil	other-chemicalthing
and	O
folinic	other-chemicalthing
acid	other-chemicalthing
for	O
pancreatic	other-disease
cancer	other-disease
following	O
failure	O
of	O
initial	O
treatment	O
.	O

Even	O
though	O
the	O
family	O
may	O
not	O
have	O
a	O
history	O
of	O
Sandhoff	other-disease
disease	O
,	O
it	O
is	O
possible	O
for	O
two	O
individuals	O
to	O
have	O
a	O
child	O
with	O
the	O
disease	O
.	O

Research	O
has	O
identified	O
over	O
2,000	O
cystic	other-disease
fibrosis	other-disease
associated	O
mutations	O
in	O
the	O
gene	O
encoding	O
for	O
the	O
cystic	other-disease
fibrosis	other-disease
transmembrane	O
conductance	O
regulator	O
at	O
varying	O
degrees	O
of	O
frequency	O
within	O
the	O
disease	O
carrying	O
population	O
.	O

Distal	other-disease
intestinal	other-disease
obstruction	other-disease
syndrome	other-disease
(	O
DIOS	other-disease
)	O
involves	O
obstruction	O
of	O
the	O
distal	O
part	O
of	O
the	O
small	O
intestines	O
by	O
thickened	O
intestinal	O
content	O
and	O
occurs	O
in	O
about	O
20	O
%	O
of	O
mainly	O
adult	O
individuals	O
with	O
cystic	other-disease
fibrosis	other-disease
.	O

In	O
May	O
of	O
2020	O
,	O
Sandringham	organization-education
Primary	organization-education
banned	O
dairy	O
products	O
from	O
school	O
grounds	O
,	O
due	O
to	O
a	O
student	O
with	O
a	O
severe	O
allergy	other-disease
to	other-disease
dairy	other-disease
.	O

Following	O
its	O
introduction	O
in	O
the	O
United	location-GPE
States	location-GPE
in	O
February	O
1984	O
,	O
ESWL	O
was	O
rapidly	O
and	O
widely	O
accepted	O
as	O
a	O
treatment	O
alternative	O
for	O
renal	other-disease
and	other-disease
ureteral	other-disease
stones	other-disease
.	O

Based	O
on	O
this	O
research	O
,	O
Merck	organization-company
developed	O
an	O
important	O
antiprotease	O
drug	O
for	O
the	O
treatment	O
of	O
AIDS	other-disease
.	O

In	O
2006	O
the	O
FDA	organization-company
expended	O
approved	O
use	O
to	O
include	O
Dermatofibrosarcoma	other-disease
protuberans	other-disease
(	O
DFSP	other-disease
)	O
,	O
Myelodysplastic/myeloproliferative	other-disease
diseases	other-disease
(	O
MDS/MPD	other-disease
)	O
,	O
Aggressive	other-disease
systemic	other-disease
mastocytosis	other-disease
.	O

Mumps	other-disease
meningitis	other-disease
typically	O
resolves	O
within	O
3–10	O
days	O
without	O
long-term	O
complications	O
.	O

The	O
exophoria	other-disease
at	O
near	O
often	O
recurs	O
after	O
several	O
years	O
,	O
although	O
most	O
patients	O
remain	O
asymptomatic	O
.	O

``	O
MDC1	other-biologything
``	O
has	O
anti-apoptotic	O
properties	O
by	O
directly	O
inhibiting	O
the	O
apoptotic	O
activity	O
of	O
the	O
tumor	other-disease
suppressing	O
protein	other-biologything
p53	other-biologything
.	O

Stuporous	O
catatonia	other-disease
is	O
characterized	O
by	O
immobility	O
during	O
which	O
patients	O
may	O
show	O
reduced	O
responsiveness	O
to	O
the	O
environment	O
(	O
stupor	O
)	O
,	O
rigid	O
poses	O
(	O
posturing	O
)	O
,	O
an	O
inability	O
to	O
speak	O
(	O
mutism	other-disease
)	O
,	O
and	O
waxy	O
flexibility	O
(	O
in	O
which	O
they	O
maintain	O
positions	O
after	O
being	O
placed	O
in	O
them	O
by	O
someone	O
else	O
)	O
.	O

caused	O
by	O
gene	O
duplication	O
)	O
results	O
in	O
CMT1A	other-disease
,	O
and	O
too	O
little	O
PMP22	other-biologything
(	O
e.g	O
.	O

This	O
phase	O
may	O
last	O
from	O
several	O
months	O
to	O
several	O
years	O
,	O
and	O
there	O
may	O
be	O
no	O
symptoms	O
of	O
leukemia	other-disease
.	O

A	O
Cochrane	O
review	O
of	O
low-level	O
laser	O
therapy	O
found	O
unclear	O
evidence	O
of	O
benefit	O
,	O
whereas	O
another	O
review	O
found	O
short-term	O
pain	O
relief	O
for	O
osteoarthritic	other-disease
knees	other-disease
.	O

Distal	other-disease
RTA	other-disease
has	O
also	O
been	O
linked	O
to	O
specific	O
genetic	O
mutations	O
that	O
will	O
alter	O
when	O
the	O
disease	O
will	O
present	O
in	O
the	O
patient	O
's	O
life	O
.	O

Healthy	O
eating	O
is	O
a	O
key	O
factor	O
in	O
wellness	O
,	O
and	O
prevention	O
of	O
chronic	O
diseases	O
,	O
such	O
as	O
diabetes	other-disease
,	O
obesity	other-disease
,	O
heart	other-disease
disease	other-disease
and	O
cancer	O
.	O

He	O
also	O
set	O
up	O
Scotland	location-GPE
's	O
endoscopic	O
surveillance	O
service	O
for	O
Barrett	other-disease
's	other-disease
esophagus	other-disease
(	O
ESBE	O
)	O
between	O
1988–1991	O
at	O
Ninewells	O
Hospital	O
of	O
Dundee	O

Studies	O
consistently	O
find	O
a	O
strong	O
association	O
between	O
increased	O
body	O
mass	O
index	O
and	O
plantar	other-disease
fasciitis	other-disease
in	O
the	O
non-athletic	O
population	O
.	O

He	O
was	O
found	O
guilty	O
of	O
rebellion	O
and	O
sentenced	O
to	O
confinement	O
in	O
the	O
dungeons	O
of	O
old	O
Fort	building-other
Marion	building-other
at	O
St.	location-other
Augustine	location-other
,	O
Florida	location-GPE
,	O
and	O
vulnerable	O
to	O
malaria	other-disease
and	O
measles	other-disease
.	O

A	O
stress	other-disease
cough	other-disease
is	O
when	O
the	O
airways	O
of	O
the	O
throat	O
are	O
blocked	O
to	O
the	O
point	O
that	O
causes	O
a	O
reflexive	O
spasm	O
.	O

Counselors	O
can	O
also	O
provide	O
some	O
psycho-education	O
on	O
alcoholism	other-disease
and	O
its	O
effects	O
on	O
family	O
members	O
of	O
alcoholics	O
.	O

Autosomal	other-disease
recessive	other-disease
polycystic	other-disease
kidney	other-disease
disease	other-disease
(	O
ARPKD	other-disease
)	O
(	O
OMIM	O
#	O
263200	O
)	O
is	O
the	O
lesser	O
common	O
of	O
the	O
two	O
types	O
of	O
PKD	other-disease
,	O
with	O
an	O
incidence	O
of	O
1:20,000	O
live	O
births	O
and	O
is	O
typically	O
identified	O
in	O
the	O
first	O
few	O
weeks	O
after	O
birth	O
.	O

Insomnia	other-disease
is	O
40	O
%	O
more	O
common	O
in	O
women	O
than	O
in	O
men	O
.	O

Two	O
disorders	O
,	O
achondroplasia	other-disease
and	O
growth	O
hormone	O
deficiency	O
,	O
are	O
responsible	O
for	O
the	O
majority	O
of	O
human	O
dwarfism	other-disease
cases	O
.	O

In	O
1918	O
,	O
the	O
Spanish	other-disease
influenza	other-disease
epidemic	other-disease
took	O
1,500	O
victims	O
in	O
a	O
month	O
.	O

It	O
usually	O
occurs	O
due	O
to	O
a	O
tracheoarterial	other-disease
fistula	other-disease
,	O
an	O
abnormal	O
connection	O
between	O
the	O
trachea	O
and	O
nearby	O
blood	O
vessels	O
,	O
and	O
most	O
commonly	O
manifests	O
between	O
3	O
days	O
to	O
6	O
weeks	O
after	O
the	O
procedure	O
is	O
done	O
.	O

All	O
known	O
prion	other-disease
diseases	other-disease
are	O
untreatable	O
and	O
fatal	O
.	O

Type	other-disease
I	other-disease
antithrombin	other-disease
deficiency	other-disease
is	O
characterized	O
by	O
a	O
decrease	O
in	O
both	O
antithrombin	other-biologything
activity	O
and	O
antithrombin	other-biologything
concentration	O
in	O
the	O
blood	O
of	O
affected	O
individuals	O
.	O

From	O
1958–1983	O
there	O
were	O
986	O
outbreaks	O
of	O
botulism	other-disease
in	O
China	location-GPE
involving	O
4,377	O
people	O
with	O
548	O
deaths	O
.	O

Our	O
knowledge	O
of	O
renal	other-disease
ischemia	other-disease
comes	O
from	O
animal	O
studies	O
.	O

Direct	O
intervention	O
for	O
psychological	O
treatment	O
of	O
childhood	other-disease
obesity	other-disease
has	O
become	O
more	O
prevalent	O
in	O
recent	O
years	O
.	O

However	O
,	O
basic	O
science	O
research	O
showed	O
that	O
many	O
cytokines	O
were	O
elevated	O
in	O
both	O
Crohn	other-disease
's	other-disease
disease	other-disease
and	O
ulcerative	other-disease
colitis	other-disease
.	O

Titers	O
to	O
GM1	other-disease
in	O
other	O
diseases	O
(	O
rheumatoid	other-disease
arthritis	other-disease
,	O
primary	other-disease
Sjögren	other-disease
's	other-disease
syndrome	other-disease
and	O
systemic	other-disease
lupus	other-disease
erythematosus	other-disease
)	O
was	O
also	O
elevated	O
.	O

Forced	O
alkaline	O
diuresis	O
has	O
been	O
used	O
to	O
increase	O
the	O
excretion	O
of	O
acidic	O
drugs	O
like	O
salicylates	other-chemicalthing
and	O
phenobarbitone	other-chemicalthing
,	O
and	O
is	O
recommended	O
for	O
rhabdomyolysis	other-disease
.	O

Dive	O
history	O
as	O
recorded	O
by	O
a	O
personal	O
dive	O
computer	O
or	O
bottom	O
timer	O
can	O
indicate	O
a	O
probability	O
of	O
gas	O
bubbles	O
being	O
a	O
consequence	O
of	O
decompression	O
sickness	O
,	O
lung	O
overpressure	O
induced	O
arterial	other-disease
gas	other-disease
embolism	other-disease
or	O
an	O
artifact	O
of	O
post	O
mortem	O
recovery	O
decompression	O
.	O

Such	O
injections	O
are	O
less	O
common	O
in	O
modern	O
medical	O
practice	O
than	O
they	O
were	O
previously	O
,	O
and	O
injections	O
of	O
gamma	O
globulin	O
previously	O
recommended	O
for	O
travelers	O
have	O
largely	O
been	O
replaced	O
by	O
the	O
use	O
of	O
hepatitis	other-disease
A	other-disease
vaccine	O
.	O

Surgery	O
of	O
the	O
anal	other-disease
fistula	other-disease
to	O
drain	O
an	O
abscess	other-disease
treats	O
the	O
fistula	O
and	O
reduces	O
likelihood	O
of	O
its	O
recurrence	O
and	O
the	O
need	O
for	O
repeated	O
surgery	O
.	O

Rates	O
of	O
schizotypal	other-disease
personality	other-disease
disorder	other-disease
are	O
much	O
higher	O
in	O
relatives	O
of	O
individuals	O
with	O
schizophrenia	other-disease
than	O
in	O
the	O
relatives	O
of	O
people	O
with	O
other	O
mental	O
illnesses	O
or	O
in	O
people	O
without	O
mentally	O
ill	O
relatives	O
.	O

That	O
incident	O
,	O
combined	O
with	O
years	O
of	O
chronic	other-disease
arthritis	other-disease
,	O
forced	O
him	O
to	O
cut	O
back	O
drastically	O
on	O
performances	O
.	O

A	O
lipodystrophy	other-disease
can	O
be	O
a	O
lump	O
or	O
small	O
dent	O
in	O
the	O
skin	O
that	O
forms	O
when	O
a	O
person	O
performs	O
injections	O
repeatedly	O
in	O
the	O
same	O
spot	O
.	O

Barotrauma	other-disease
generally	O
manifests	O
as	O
sinus	other-disease
or	O
middle	other-disease
ear	other-disease
effects	other-disease
,	O
decompression	other-disease
sickness	other-disease
(	O
DCS	other-disease
)	O
,	O
lung	other-disease
overpressure	other-disease
injuries	other-disease
and	O
injuries	O
resulting	O
from	O
external	O
squeezes	O
.	O

The	O
size	O
of	O
the	O
monocular	other-disease
scotoma	other-disease
is	O
5×7	O
degrees	O
of	O
visual	O
angle	O
.	O

Several	O
techniques	O
and	O
types	O
of	O
catheter	O
are	O
available	O
,	O
including	O
sterile	O
(	O
single-use	O
)	O
and	O
clean	O
(	O
multiple	O
use	O
)	O
catheters	O
,	O
but	O
,	O
based	O
on	O
current	O
information	O
,	O
none	O
is	O
superior	O
to	O
others	O
in	O
reducing	O
the	O
incidence	O
of	O
urinary	other-disease
tract	other-disease
infection	other-disease
.	O

Beers	person-other
was	O
diagnosed	O
with	O
Osteochondritis	other-disease
dissecans	other-disease
in	O
2006	O
,	O
at	O
the	O
age	O
of	O
12	O
.	O

The	O
gastroduodenal	O
artery	O
can	O
be	O
the	O
source	O
of	O
a	O
significant	O
gastrointestinal	O
bleed	O
,	O
which	O
may	O
arise	O
as	O
a	O
complication	O
of	O
peptic	other-disease
ulcer	other-disease
disease	other-disease
.	O

Other	O
example	O
could	O
be	O
AIDS	other-disease
,	O
where	O
an	O
HIV	other-biologything
infection	O
can	O
produce	O
several	O
clinical	O
stages	O
.	O

The	O
effectiveness	O
of	O
both	O
aspirin	O
and	O
clopidogrel	O
,	O
to	O
reduce	O
risk	O
of	O
cardiovascular	O
ischemic	O
events	O
in	O
people	O
with	O
symptomatic	O
PAD	other-disease
is	O
not	O
well	O
established	O
.	O

People	O
with	O
chronic	other-disease
breathing	other-disease
disorders	other-disease
such	O
as	O
asthma	other-disease
use	O
this	O
as	O
a	O
bronchodilator	O
to	O
make	O
breathing	O
easier	O
.	O

On	O
October	O
23	O
,	O
2020	O
,	O
an	O
article	O
from	O
The	O
Denver	organization-media,newspaper
Post	organization-media,newspaper
revealed	O
that	O
in	O
late	O
September	O
2020	O
,	O
Moor	person-athlete
had	O
taken	O
up	O
a	O
temporary	O
roll	O
as	O
a	O
player-coach	O
with	O
Colorado	location-GPE
amid	O
a	O
COVID-19	other-disease
outbreak	O
that	O
left	O
the	O
entire	O
coaching	O
staff	O
unavailable	O
.	O

DiNovo	organization-government,governmentagency
successfully	O
proposed	O
a	O
bill	O
to	O
recognize	O
Post-Traumatic	other-disease
Stress	other-disease
Disorder	other-disease
(	O
PTSD	other-disease
)	O
as	O
a	O
work	O
place	O
injury	O
for	O
first	O
responders	O
fast-tracking	O
their	O
Workplace	organization-other
Safety	organization-other
and	organization-other
Insurance	organization-other
Board	organization-other
benefits	O
.	O

A	O
pseudocyst	other-disease
stage	O
has	O
been	O
recorded	O
and	O
may	O
be	O
the	O
form	O
taken	O
during	O
transmission	O
via	O
the	O
fecal-oral	O
route.7,8	O

Jenner	person-other
extracted	O
the	O
pus	O
of	O
one	O
of	O
the	O
lesions	O
formed	O
by	O
cowpox	other-disease
on	O
Nelmes	person-other
to	O
another	O
individual	O
who	O
had	O
never	O
had	O
smallpox	other-disease
,	O
an	O
eight-year-old	O
boy	O
called	O
James	person-other
Phipps	person-other
.	O

Geneticists	O
studying	O
these	O
premature-aging	other-disease
syndromes	other-disease
propose	O
that	O
caretaker	other-biologything
genes	other-biologything
that	O
determine	O
cell	O
fate	O
also	O
play	O
a	O
significant	O
role	O
in	O
aging	O
.	O

However	O
,	O
the	O
number	O
of	O
symptoms	O
and	O
severity	O
of	O
symptoms	O
may	O
depend	O
on	O
how	O
severe	O
the	O
anemia	other-disease
is	O
.	O

Mitochondrial	other-disease
acetoacetyl-CoA	other-disease
thiolase	O
deficiency	O
,	O
known	O
earlier	O
as	O
β-ketothiolase	O
deficiency	O
,	O
is	O
an	O
inborn	O
error	O
of	O
metabolism	O
involving	O
isoleucine	O
catabolism	O
and	O
ketone	O
body	O
metabolism	O
.	O

When	O
Cowden	other-disease
syndrome	other-disease
and	O
Cowden-like	other-disease
syndrome	other-disease
are	O
caused	O
by	O
SDHD	other-biologything
gene	O
mutations	O
,	O
the	O
conditions	O
are	O
associated	O
with	O
a	O
particularly	O
high	O
risk	O
of	O
developing	O
breast	O
and	O
thyroid	other-disease
cancers	other-disease
.	O

False	other-disease
memory	other-disease
syndrome	other-disease
is	O
a	O
condition	O
in	O
which	O
a	O
person	O
's	O
identity	O
and	O
interpersonal	O
relationships	O
center	O
on	O
a	O
memory	O
of	O
a	O
traumatic	O
experience	O
that	O
is	O
objectively	O
false	O
but	O
that	O
the	O
person	O
strongly	O
believes	O
occurred	O
.	O

In	O
many	O
cases	O
,	O
however	O
,	O
especially	O
in	O
people	O
with	O
alcoholic	other-disease
intoxication	other-disease
,	O
hypoglycemia	other-disease
appears	O
to	O
be	O
a	O
more	O
common	O
cause	O
.	O

K562	other-biologything
cells	other-biologything
are	O
of	O
the	O
erythroleukemia	other-disease
type	O
,	O
and	O
the	O
cell	O
line	O
is	O
derived	O
from	O
a	O
53-year-old	O
female	O
chronic	other-biologything
myelogenous	other-biologything
leukemia	other-disease
patient	O
in	O
blast	O
crisis	O
.	O

Protein	other-biologything
C	other-biologything
in	O
plasma	O
in	O
the	O
steady	O
state	O
has	O
a	O
half	O
life	O
of	O
6-	O
to	O
10-hour	O
,	O
therefore	O
,	O
patients	O
with	O
severe	O
protein	other-disease
C	other-disease
deficiency	other-disease
and	O
presenting	O
with	O
purpura	other-disease
fulminans	other-disease
can	O
be	O
treated	O
acutely	O
with	O
an	O
initial	O
bolus	O
of	O
protein	other-biologything
C	other-biologything
concentrate	O
100	O
IU/kg	O
followed	O
by	O
50	O
IU	O
/kg	O
every	O
6	O
hours	O
.	O

Some	O
studies	O
have	O
shown	O
that	O
1	O
in	O
every	O
7	O
couples	O
will	O
fail	O
to	O
conceive	O
due	O
to	O
infertility	other-disease
problems	O
.	O

During	O
the	O
conference	O
's	O
closing	O
ceremonies	O
,	O
United	organization-other
Nations	organization-other
Special	organization-other
Envoy	organization-other
for	organization-other
HIV/AIDS	organization-other
in	O
Africa	location-GPE
Stephen	person-other
Lewis	person-other
pointed	O
out	O
the	O
failure	O
of	O
South	location-GPE
Africa	location-GPE
's	O
response	O
to	O
HIV	other-disease
/	O
AIDS	other-disease
,	O
calling	O
their	O
actions	O
more	O
``	O
[	O
more	O
]	O
worthy	O
of	O
a	O
lunatic	O
fringe	O
than	O
of	O
a	O
concerned	O
and	O
compassionate	O
state	O
.	O
''	O

Also	O
,	O
ketotic	other-disease
hypoglycemia	other-disease
has	O
been	O
reported	O
in	O
several	O
individuals	O
and	O
usually	O
presents	O
itself	O
around	O
the	O
age	O
of	O
three	O
.	O

NAMRU-3	organization-other
through	O
a	O
collaboration	O
with	O
the	organization-other
WHO	organization-other
in	O
the	O
early	O
1970s	O
was	O
instrumental	O
in	O
developing	O
typhoid	other-disease
and	O
Group	O
A	O
Meningococcal	O
meningitis	O
vaccines	O
.	O

In	O
patients	O
suffering	O
from	O
demyelinating	other-disease
neuropathy	other-disease
,	O
symptoms	O
are	O
due	O
to	O
slow	O
nerve	O
conduction	O
velocities	O
,	O
however	O
people	O
with	O
axonal	other-disease
degradation	other-disease
have	O
average	O
to	O
normal	O
nerve	O
conduction	O
velocities	O
.	O

Although	O
what	O
causes	O
pedophilia	other-disease
is	O
not	O
yet	O
known	O
,	O
researchers	O
began	O
reporting	O
a	O
series	O
of	O
findings	O
linking	O
pedophilia	other-disease
with	O
brain	O
structure	O
and	O
function	O
,	O
beginning	O
in	O
2002	O
.	O

Like	O
dopamine	other-biologything
,	O
norepinephrine	other-biologything
,	O
and	O
serotonin	other-biologything
,	O
the	O
trace	other-biologything
amines	other-biologything
have	O
been	O
implicated	O
in	O
a	O
vast	O
array	O
of	O
human	O
disorders	O
of	O
affect	O
and	O
cognition	O
,	O
such	O
as	O
ADHD	other-disease
,	O
depression	other-disease
and	O
schizophrenia	other-biologything
,	O
among	O
others	O
.	O

Furthermore	O
,	O
nitric	other-chemicalthing
oxide	other-chemicalthing
may	O
cause	O
kidney	O
damage	O
and	O
is	O
not	O
recommended	O
as	O
therapy	O
for	O
ARDS	other-disease
regardless	O
of	O
severity	O
.	O

In	O
left	O
ventricular	other-disease
failure	other-disease
,	O
evidence	O
may	O
exist	O
of	O
vascular	O
redistribution	O
(	O
upper	other-disease
lobe	other-disease
blood	other-disease
diversion	other-disease
or	O
cephalization	other-disease
)	O
,	O
Kerley	O
lines	O
,	O
cuffing	O
of	O
the	O
areas	O
around	O
the	O
bronchi	O
,	O
and	O
interstitial	other-disease
edema	other-disease
.	O

He	O
was	O
a	O
Christian	organization-religion
Scientist	O
and	O
Sean	person-scholar
Ely	person-scholar
believed	O
his	O
father	O
suffered	O
from	O
skin	other-disease
cancer	other-disease
.	O